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1 Introduction 
1.1 Intestinal immune system  
The mucosal immune system has the complex task of responding to a vast number of ingested 
antigens. Under normal physiological conditions, immunological tolerance is induced to food 
and commensal bacteria whereas potential effector immune response occurs against 
pathogenic microorganisms. The immune system has a series of anatomically distinct 
compartments specialized to combat pathogen in a particular site of the body. For example 
peripheral lymph nodes and spleen respond to antigens that have entered the tissue or 
spreaded into the blood. Another compartment of the immune system is the mucosa 
associated lymphoid tissue or MALT which guards the surfaces of the body, e.g. lungs, gut, 
eyes, nose, mouth, throat, uterus and vagina etc. These surfaces are permeable to some extent 
due to their physiological functions and thus vulnerable to infection. For the gut it is more 
crucial as its physiological function is to absorb foreign antigens as food. It has to avoid 
immune reaction against food materials and commensal microorganisms but mount immune 
response to kill pathogenic organisms. This immune system lining the gut is known as gut 
associated lymphoid tissue or GALT. It is comprised of organized lymphoid tissue as well as 
small foci of lymphocytes and plasma cells scattered throughout the lamina propria of the gut 
wall. 
Gut associated lymphoid tissue (GALT) comprises:  
 tonsils, adenoids (Waldeyer's ring)  
 Peyer's patches  
 lymphoid aggregates in the appendix and large intestine  
 lymphoid tissue accumulating with age in the stomach  
 small lymphoid aggregates in the oesophagus  
 diffusely distributed lymphoid cells and plasma cells in the lamina propria of the gut  
Peyer’s patches (PP) are aggregates of lymphoid follicles in the small bowel especially in the 
distal ileum. They form a domelike structure extending into the lumen of the intestine. The 
overlying layer of Peyer's patches contains specialized epithelial cells which have microfolds 
on their luminal surface and are called M cells. M cells are believed to be important in the 
transfer of antigen from the gut lumen to Peyer's patches. Peyer's patches facilitate the 
generation of an immune response within the mucosa. B cell precursors and memory cells are 
stimulated by antigen in Peyer's Patches. 
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GALT comprises various cell types, such as granulocytes and macrophages which form part 
of the innate immune system and provide non specific immunity and lymphocytes which 
mediate adaptive immunity. Figure 1 presents the organization of various cell types and 
factors involved in GALT. 
              
 
Figure 1: Gut Associated Lymphoide tissue (GALT). The epithelium overlying organized 
GALT contains specialized M cells that constantly transport gut bacteria and antigens from the gut 
lumen into the lymphoid tissue. DC in the lamina propria (LP) extends dendrites through epithelial 
cells to the lumen and also sample gut bacteria. The epithelium is filled with CD8+ T cells, and the LP 
contains many CD4+ T cells, macrophages, and IgA antibody–producing plasma cells. Potentially 
tissue-damaging T cell responses may be inhibited by immunosuppressive cytokines and regulatory T 
cells (64).  
 
1.1.1 Physical barrier at the mucosal surface: Mucus, antimicrobial peptides.  
The specialized architecture of the intestinal epithelium forms a tight barrier against the 
penetration of microorganisms. Tight junctions between the IECs (Intestinal epithelial cells) 
are involved in the barrier function of the epithelium (117). The physical barrier is supported 
by a thick layer of mucus containing diverse mucins. Goblet cells present both in the crypt 
and villus epithelium throughout the small intestine, colon and rectum produce mucus. The 
mucus layer forms a semipermeable protective barrier, helps to accelerate intestinal repair 
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especially by intestinal trefoil factor, also traps bacteria in the mucus flow and thus washes 
away by intestinal peristalsis. 
 
1.1.2 Innate and adaptive immunity at the intestinal mucosa 
Intestinal homeostasis is maintained by finely tuned balance between immune response and 
tolerance to the luminal microorganisms. Two effectors are responsible for innate immune 
response, antimicrobial peptides such as defensins and neutrophils. Defensins are amphipathic 
in character, interact with and lyse bacterial cell wall (125). In microbial colonization 
neutrophils are recruited to the basal side of IECs mainly in response to IL-8 produced by 
epithelial cells. Neutrophils then translocate through epithelial lining and in the gut lumen 
exert their antibacterial function (92). In addition to maintaining physical and innate immune 
barrier functions, the intestinal epithelium also takes part in the induction of an effective 
adaptive immune response at the intestinal mucosa with IEC together with antigen presenting 
cells and lymphoid cells. It occurs in follicle associated epithelium (FAE) which contains M 
cells (92).  
M cells are much less prominent than absorptive gut epithelial cells, enterocytes. M cells are 
available on the membrane overlying Peyer’s patches. M cells are adapted to interact directly 
with molecules and particles within the lumen of the gut and hence do not have thick mucus 
layer on them and also do not secrete mucus. M cells take up molecules and particles from the 
gut lumen by endocytosis or phagocytosis, transport them through the interior of the cell in 
vesicles to the basal cell membrane and release them into the extracellular space. This M cell 
mediated transport of antigen from lumen is called transcytosis. Lymphocytes and antigen 
presenting cells present at the basal surface of M cells take up this material transported by M 
cells and process it for antigen presentation. Some pathogens use M cells as a port of entry to 
subepithelial region.  
Luminal microorganisms can also be captured by dendritic cells (DC) that extend pseudopods 
across the IECs of the epithelial lining and retract these processes before trafficking to 
immunocompetent sites with their bacterial cargo. Mucosal effector mechanisms include 
humoral factors e.g. secretory IgA as well as cellular factors of B cells, T cells and 
lymphocytes unique to GALT (92). 
The major antibody isotype present in the lumen of gut is secretory IgA (sIgA). In blood, 
IgA is found mainly in monomeric form but in mucosal secretions it is found as a dimer and 
mostly IgA2 form. IgA in gut is synthesized by plasma cells located in the lamina propria and 
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is transported to the lumen by immature epithelial cells present at the base of the intestinal 
crypts which express polymeric immunoglobulin receptor at their basolateral surface. 
Secreted IgA binds to the mucus layer overlying the gut epithelium where it can bind to and 
neutralize gut pathogens and their toxic products. IgA acts in cooperation with non-
immunological defense mechanisms to mediate immune exclusion of foreign antigens by 
preventing epithelial adherence and penetration of invasive pathogenic microorganisms, 
neutralizing toxins and viral multiplication (20). 
Antigen presenting cells: Dendritic cells are a widely distributed, migratory group of bone-
marrow derived leukocytes that are specialized for the uptake, transport and presentation of 
antigens to T cells (38,70,107). At an immature stage of development DC act as sentinels in 
peripheral tissue continuously sampling antigens. When these DC encounter microbial 
products, they process them and present them on the cell surface loaded on MHC molecules. 
During antigen processing DC migrate to lymph nodes, become mature which is evident by 
up regulating costimulatory molecules, and these mature DCs interact with T cells containing 
specific receptor for the antigen loaded on MHC at the cell surface of DC (103).  
Mucosal DC takes up antigens in several ways interacting with intestinal epithelial cells. In 
organized mucosal tissues, such as PP and colonic follicles, M cells directly delivers antigen 
from the lumen to underlying DCs. At the terminal ileum DCs extend transepithelial 
processes through intestinal epithelia lining the gut lumen to sample luminal antigens and 
microbes directly. Richard Blumberg (129) proposed another mechanism. Neonatal Fc 
receptors mediate the bidirectional transport of IgG, resulting in transport into the lumen and 
trafficking back the antigen antibody complex to the lamina propria. Due to neonatal Fc 
receptor, antigen antibody complex is not degraded in epithelial cells and is taken up by 
underlying DC. DC can also take up and process antigens from apoptotic intestinal epithelial 
cells (50). DC sense the microbe by recognizing evolutionarily conserved molecular patterns 
that are integral to microbial carbohydrates, lipids and nucleic acids through pattern 
recognition receptors (PRR) (47). Toll like receptors are prime members of these PRRs (85). 
DCs consist of several phenotypically distinct subsets that differ in their microenvironmental 
localization, migration potential, PRR expression, responsiveness to microbes, and their 
capacity to induce and regulate distinct arms of the innate and adaptive immune systems. 
Major DC subsets in human blood are plasmacytoid DC, interstitial DC and Langerhans DC. 
In mice the major DC subsets in secondary lymphoid organs are lymphoid DC (CD8α+), 
myeloid DC (CD8α-), plasmacytoid DC and langerhans DC (83). 
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DC sample intestinal bacteria either directly or can engulf them after being transported by M 
cells. DCs present these antigenic peptides from captured microbes to B and T lymphocytes 
either locally at GALT or within the mescenteric lymph nodes (MLN) that drain the gut 
submucosa. Presentation of microbial antigens to B cells triggers production of a commensal 
specific IgA response that prevents the commensals from spreading beyond the gut mucosa 
where they could elicit a systemic inflammatory response (53). 
 
T cells: T lymphocytes originate in the bone marrow and then develop in thymus and play a 
key role in adaptive immunity. T lymphocytes are subdivided into CD4+ T helper cells and 
CD8+ cytotoxic T cells. CD4+ T cells are further subdivided according to their effector 
function in T helper 1 (Th1) and T helper 2 (Th2) and regulatory T cells. Th1 cells secrete 
IFN-γ and activate macrophages whereas Th2 cells secrete cytokines IL-4, IL-10 and activate 
B cells to produce antibodies. T cells are also classified according to their T cell receptor 
(TCR) type, αβ T cells and γδ T cells. In the gut there are αβ T cells bearing CD4 or CD8. 
They participate the conventional T helper or cytotoxic function against foreign antigens. 
There are some unusual T cells, e.g. CD8ααTCRαβ T cells. TCRγδ Τ cells are especially 
abundant in the gut mucosa compared to other lymphoid tissues. A subset of these T cells 
specifically recognizes injured epithelial cells and destroys them. γδ Τ cells may also have a 
role in oral tolerance, because tolerance appears to be reduced in mice lacking this subset of T 
lymphocytes. 
 
Regulatory T cells: There are two possible and opposite outcomes of exposure to foreign 
antigens through the mucosa of the gut. There is often tolerance to food antigens but vigorous 
antibody and T cell response against pathogens. T cells specific for food antigens are either 
deleted by apoptosis, or become anergic that is refractory to further antigenic stimulation or 
suppressed by regulatory T cells. Th3 cells in Peyer’s patches are involved in oral tolerance 
(antigen specific nonresponse to an antigen given by oral route) and secrete TGF-β (122,123). 
Another class of regulatory T cells named Tr1 (T regulatory cell 1) secretes IL-10 and inhibits 
the development of an inflammatory T cell response as well as reduces antibody response.  
 
1.1.3 Microflora 
The gastrointestinal (GI) tract of human adults contains more than 400 different species of 
bacteria. From birth to death we are colonized by a vast complex and dynamic array of 
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microorganisms. Most of these bacteria are commensals that coexist peacefully with their 
host, remain harmless and also do not spread beyond the gut lumen. Some commensals even 
are beneficial to the host (53). The commensals are not just randomly distributed throughout 
the GI tract of adults but are found differently distributed at different regions of the tract. The 
oral cavity contains microflora containing 200 species shed from oral surface such as tongue 
and cheeks (36). The human stomach and the upper two-thirds of the small intestine 
(duodenum and jejunum) contain low numbers of microbes due to low pH and relatively swift 
flow of stomach contents (113). The upper small intestine contains mainly acid tolerant 
lactobacilli and streptococci. In the distal small intestine (ileum) bacteria number increases to 
108 bacteria /ml with decreased peristalsis and lower oxidation-reduction potentials. The large 
intestine (colon) is the primary site for microbial colonization (1010-1011bacteria/g) in humans 
and animals probably because of the slow intestinal motility encountered here and the very 
low oxidation-reduction potentials. 99.9% of the GI microflora is obligate anaerobe. There is 
also a difference in bacterial distribution horizontally in GI lumen, mucus layer lining the 
intestinal surface, deep layer of mucus at intestinal crypt and immediate surface of mucosal 
epithelial cell.  
The microflora has some beneficial effects to the host. Microflora helps the host by interfering 
with further bacterial colonization, helps in the development of mucosal immune system, 
maintains GI tract peristalsis and intestinal mucosal integrity, detoxifies carcinogens by 
converting it to noncarcinogens and also produces vitamin K and B complex (9). The 
relationship between host and gut microbes can shift from commensalisms toward 
pathogenicity in certain diseases. The pathogenesis of IBD appears to involve an 
‘inappropriate’ activation of the mucosal immune system due to a loss of tolerance to gut 
commensals (43). 
 
1.1.4 Intestinal homeostasis 
In order to maintain intestinal homeostasis in the gut, the immune system must tightly 
regulate cellular responsiveness and maintain a balance between active immunity and 
tolerance. Loss of tolerance to gut flora develops IBD (10). After a productive immune 
response to a foreign antigen, the immune system returns to a state of rest, so that the numbers 
and functional status of lymphocytes are reset to normal state by different mechanisms shown 
in figure 2. In several colitis models as well as our model of IL-2-/- mice one or more 
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mechanisms responsible to bring back the immune system to basal level after an immune 
response is disturbed. 
 
 
Figure 2: Mechanism of active termination of immune responses. A normal T cell response 
is triggered by the recognition of antigen and the co stimulatory signal. Multiple mechanisms may 
function to inhibit the expansion or/and effector functions of T lymphocytes. These mechanisms 
appear to be most important for the maintenance of self-tolerance (118). 
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1.2 Inflammatory bowel diseases 
Inflammatory bowel diseases (IBD) are chronic relapsing inflammatory disorders of the 
gastrointestinal tract. Approximately 0.1 percent of the western population suffer from 
Inflammatory bowel diseases (106). Disease incidence is the highest in developed, urbanized 
countries (12). About 20% of the individuals with Crohn’s disease (CD) have a relative with 
some form of IBD. The age of onset is between 15 to 30 years, but both younger and older 
individuals may be affected (13).  
IBD is a multifactorial disease, depends on genetics, environment and immune function of the 
individual (30). Most generally accepted pathogenesis of IBD is that it results from abnormal 
immune response to enteric bacteria in individuals with susceptibility due to polygenic defects 
(131). Microbial agents are intimately involved in four current hypotheses of IBD, first, 
persistent infection with a pathogen (e.g. Mycobacterium tuberculosis, Listeria 
monocytogenes in Crohn’s disease and pathogenic E. coli in ulcerative colitis), second, subtle 
alteration in bacterial function and composition, third, altered mucosal barrier, e.g. defective 
mucus, tight junctions, epithelial restitution, fourth, defective regulation of mucosal immune 
response, e.g. less down regulation and aggressive induction of immune response (28). There 
are two main forms of IBD, Crohn’s disease (CD) and ulcerative colitis (UC). 
 
1.2.1 Crohn’s disease 
Crohn’s disease is a transmural (affecting all layers of bowel), dense infiltration of 
lymphocytes and macrophages, with presence of granulomas in up to 60% of the patients, 
fissuring ulceration and submucosal fibrosis. Any part of the gastrointestinal tract can be 
affected, but most commonly the terminal ileum, cecum, pre-anal area and colon. It is 
characterized by the presence of segments of normal bowel between affected regions, known 
as skip lesions (12). Clinical features associated with Crohn’s disease are dirrhoea, pain, 
narrowing of the gut lumen leading to strictures and bowel obstruction, abscess formation and 
fistulization to skin and internal organs (12). 
 
1.2.2 Ulcerative colitis 
The inflammatory process invariably involves the rectum and extends proximally in a 
continuous fashion, remaining restricted to the colon. Sometimes it is limited to the rectum as 
ulcerative proctitis. Inflammation affects superficial (mucosal) layers with infiltration of 
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lymphocytes and granulocytes and loss of goblet cells, and presence of ulceration and crypt 
abscesses (12). Ulcerative colitis is characterized by severe dirrhoea, blood loss and 
progressive loss of peristaltic function leading to a rigid colonic tube. In severe case, it leads 
to ‘toxic megacolon’ and perforation. 
 
1.2.3 Cellular elements involved in IBD 
Antigen presenting cells: APC in mucosal tissue are key cells to induce effector and 
regulatory cell response. A defect in T cell response which is the main cause of disease for 
most of the animal models of IBD may arise either from APC function or APC-T cell 
interactions. Macrophages, a type of APC are activated in mucosal inflammation and function 
mainly as effector cells. 
 
T cells: T cells play multiple roles in mucosal inflammation both as effector cells and 
regulatory cells. CD4+ effector T cells are one of the main cells infiltrating mucosal tissues in 
IBD and their deletion ameliorates inflammation. The role of CD8+ T cell is not clear as its 
deletion has no effect on intestinal immunity though increased cytotoxic T cell function has 
been observed in some of the models (104). γδ T cells which are confined to intra-epithelial 
compartment do not play an important role as effector cells in any form of colitis. There are 
different regulatory T cells. Th3, TGF-ß secreting T cells which are induced by antigen 
feeding (109) and in response to microflora, termed as oral tolerance and IL-10 secreting 
regulatory T cells (Tr1) which have poor proliferative capacities. Recently it has been shown 
that both IL-10 and IFN-γ are necessary for later ones induction (60). These T cells establish a 
mucosal homeostasis that ensures that most mucosal responses are self limited and do not 
result in inflammation. Failure in this homeostasis results in IBD which is obvious from a 
number of mouse models of IBD (12). 
 
B cells: B cells play a role in either induction of mucosal inflammation or its maintenance. 
Autoantibodies are found in some models of colitis as well as in human IBD (109). In colitis 
model ‘TCR-α chain deficiency’, B cells have a protective role (73).  
 
Epithelial cells: Epithelial cells form a barrier against exposure to mucosal microflora and 
other mucosal antigens and thus play a key role in the down regulation of mucosal immune 
responses. It is obvious in several colitis models that alterations in this barrier are the primary 
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cause of colitis (41,80) whereas in other models change in barrier is a secondary factor for 
mucosal inflammation (66). Epithelial cells also function as sensors of the bacterial 
microenvironment. They release chemokines that draw leukocytes in peri-epithelial regions 
which also can play a role in the initiation of mucosal inflammation (109). 
 
1.2.4 Probiotic therapy in IBD 
Probiotics are microbial species that exert beneficial effects on the host (93). Some 
commensal organisms from the intestinal flora have health-promoting properties and are used 
as probiotics to treat IBD (37). The gastrointestinal tract has developed redundant  
Table 1: Mechanisms of action of probiotic agents (93). 
Inhibit growth of pathogenic enteric bacteria 
Decrease luminal pH 
Secrete bactericidal proteins 
Stimulate defensin production by epithelial and Paneth cells 
Resist colonization (occupy ecologic niche)  
 
Block epithelial attachment or invasion by pathogens 
Block epithelial binding by inducing of MUC 2 
Stimulate mucus production to alter biofilm 
Inhibit epithelial invasion, Rho dependent and independent 
pathways 
 
Improve epithelial and mucosal barrier function 
Produce short-chain fatty acids, including butyrate 
Enhance mucus production 
Increase barrier integrity 
 
Alter host immune response 
Induce IL-10, TGF-β and Cox2 (PGE2) expression and secretion 
Stimulate secretory IgA production 
Decrease TNF-α, IFN-γ expression 
Activate regulatory T cells 
 
Genetic engineering 
Express and secrete IL-10 and trefoil factors 
 
mechanisms to coexist with its resident microflora, to rapidly respond to invading pathogens 
and then return to homeostasis with its commensals after the pathogenic infection is cleared. 
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When these homeostatic mechanisms are perturbed, chronic intestinal inflammation develops 
(95,100). Among commensals some bacteria are beneficial and some are aggressive and 
detrimental. Both animal model and human studies suggest that environmental and genetic 
factors govern the relative balance of beneficial and detrimental bacterial species and that 
therapeutic manipulation of this balance can influence health and disease (95,96). One of 
these therapeutic approaches is administration of probiotics to alter the composition of 
microflora towards the more protective bacteria. E. coli Nissle 1917 is able to maintain 
remission of quiescent ulcerative colitis. Probiotics can also reverse active ulcerative colitis. 
Treatment of Crohn’s disease with probiotics continues to be unsubstantiated, although 
several small trials suggest an ability to prevent relapse of quiescent disease (93). Probiotics 
are more efficient in preventing relapse of inflammation and infection than reversing 
established disease. Administration of existing probiotic preparations transiently increases 
luminal concentrations without permanently colonizing the intestine (93). Probiotic microbial 
agents and their components exert their protective effect through different mechanisms 
summarized in table1. 
 
 
1.3 Models for colitis 
The study of initiating factors in human IBD is difficult as the clinical materials are from the 
later stage of the disease. So, new experimental animal models of IBD are giving many clues 
about the early events of human IBD. Studies on animal models of mucosal inflammation 
started 60 years ago to understand the pathogenesis of human IBD (109). There is much 
development in this field and different models helped to understand some key points of IBD. 
These models explained key roles of microflora and epithelial barrier, over reactive 
lymphocytes or lack of regulatory lymphocytes in mucosal inflammation.  
 
1.3.1 Classification of animal models  
Animal models of intestinal inflammation can be divided in four categories: spontaneous 
models, inducible models in mice with normal immune system, adoptive transfer models in 
immunocompromised hosts, and genetically engineered models (transgenic mice, knockout 
mice).  
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Table 2 Characteristics of animal models of chronic intestinal inflammation [Adapted 
from (127)] 
Model Pathology Affected sites 
Spontaneous model  
C3H/HeJBir Acute, chronic transmural Cecum, right colon 
Inducible model 
DSS 
 
TNBS 
Acute, chronic  
mainly mucosal 
Acute, chronic transmural 
Colon 
 
Colon 
Adoptive transfer model models  
CD4+CD45RBhi transfer into  
SCID or RAG deficient mice 
Acute, chronic transmural Colon, duodenum 
Genetically engineered or transgenic 
IL-2 knockout mice 
IL-10 knockout mice 
 
STAT4 transgenic 
Acute, chronic mucosal 
Acute, chronic transmural 
 
Acute, chronic transmural 
Colon 
Colon, sometimes 
jejunum/ileum 
Colon, ileum 
 
In a spontaneous model of colitis, C3H/HeJBir mice develop colitis spontaneously with 
microflora reactive CD4+ T cells. In an inducible model for colitis, e.g. feeding mice for 
several days with DSS, the epithelial barrier is destroyed resulting in chronic lesions with 
infiltrating macrophages, CD4+ T lymphocytes and fissuring ulcers. In an adoptive transfer 
model, transfer of CD4+CD45RBhi T cells from wild type donor mice to immunodeficient 
SCID mice or RAG deficient mice causes a wasting syndrome with transmural intestinal 
inflammation by a proinflammatory IL-12 driven Th1 response by CD4+CD45RBhi cells 
(127). Bacterial antigens play a crucial role for the pathology because antibiotic treatment or 
germ free breeding of recipient SCID mice is associated with significantly less bowel 
inflammation (2). In genetically engineered models, IL-2-/- mice develop IBD associated with 
increased levels of IFN-γ, TNF-α and IL-1ß indicating an activation of the Th1 pathways 
(29,101).  
 
1.3.2 Mechanism for colitis development  
It is obvious from the above discussion that multiple factors are involved in the onset of 
pathogenesis in these colitis models. But they usually follow a final common pathway of 
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inflammation mediated by CD4+ T cells, either by Th1 T cell response associated with 
excessive IL-12, TNF-α, IFN-γ secretion or an excessive Th2 cell response associated with 
increased IL-4, IL-5 secretion (109). The different colitis models that follow either of these 
models are summarized at table 3.  
 
Table 3: Models for intestinal inflammation classified by nature of T cell-mediated 
inflammation (109). 
Th1 models Th2 models 
TNBS colitis(SJL/J mice) 
DSS colitis 
SCID-transfer colitis 
TCR Tg mice with lymphopenia 
IL-10 deficiency colitis 
C3H/HeJBir 
Samp1/yit mice 
T-bet Tg mice  
STAT4 Tg mice 
IL-2 deficiency colitis  
HLA-B27 Tg rats 
TCR-α chain deficiency 
TNBS-colitis in BALB/c mice 
Oxazalone colitis 
WASP deficiency 
 
Mucosal immune responses are finely tuned by opposing mechanisms, effector cell and 
regulatory mechanism. Regulatory mechanism has two faces, T cell anergy or deletion or 
regulatory T cells. Models of mucosal inflammation can be classified in two broad categories, 
Type1 models where the cause of IBD is exacerbated effector T cell function, e.g. STAT4 
transgenic mice and type 2 models where T regulatory function is impaired, e.g. IL-2 
knockout mice (109). 
 
1.3.3 Immunophysiology of normal mucosa: 
The prevailing adaptive immune effector mechanism throughout the gut is the secretory IgA 
that performs immune exclusion at the epithelial surface. In normal conditions mucosal T 
cells are primed memory T cells with little CD25 on their surface which reflects no recent 
activation. The well balanced immunological homeostasis in the intestinal mucosa breaks 
down in IBD. The mucosal microvascular endothelium expresses more adhesion molecules 
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that favor recruitment of more B and T cells (15,16). This leads to an accumulation of large 
number of potentially proinflammatory IgG-producing plasma cells and recruitment of 
monocytes like macrophages with aggressive properties as well as T cells showing various 
antimicrobial specificities directed against the commensal microbiota (17-19,65). Preferential 
overproduction of the IgG1 subclass compared to IgG2 is seen in UC, apical deposits of IgG1 
together with complement activation on the surface epithelium causes cytotoxic immune 
attack directed against brush border antigen(s) (13). IBD lesions contain many recently 
recruited and activated T cells and macrophages (CD14+) and neutrophils with increased 
capacity for production of proinflammatory cytokines, particularly IL-1 and TNF as well as 
reactive metabolites of oxygen and nitrogen. Stimulation by the LPS of gram negative 
bacteria from invading microflora by CD14 and TLR4 probably skews the local immune 
response towards a Th1 profile (14). The activated Th1 cells appear to be particularly long 
lived because IL-12, as well as complexes of IL-6 and soluble IL-6 receptor induce 
antiapoptotic mechanisms (78). A strong persistent Th1 response may thus override 
regulatory intestinal CD4+T cells that normally perform active suppression by secreting IL10 
(Tr1) or TGF-ß (Th3) as part of mucosal tolerance maintenance (75). Thus perturbation of a 
tightly controlled cytokine network, with abnormal crosstalk between several mucosal cell 
types, appears to be the first step of a progressive immunopathological cascade reaction in 
IBD (13).  
 
 
1.4 IL-2-/- mice as a colitis model 
 
1.4.1 IL-2, its receptor and physiological role 
IL-2 is a four bundled α-helical cytokine produced mainly by activated T lymphocytes (67). 
There is also evidence of IL-2 expression by naïve CD8+ T cells, dendritic cells and thymic 
cells (6,21,34,128). In T cells IL-2 synthesis is tightly regulated at the mRNA level by signals 
from the TCR and CD28 (82).  
IL-2 binds to and signals through a receptor complex consisting of three subunits named IL-
2Rα (CD25), IL-2Rβ (CD122) and common γ chain (γc, CD132) leading to activation of 
signal transducer and activator of transcription 5 (STAT5) (67,77). IL-2, via interacting the 
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Table 4: IL-2 exerts pleiotropic effects on different cells. Effect of IL-2 on immune cells 
are summarized here (33).  
Cell type Primary activities of IL-2 
CD4+ T cells Induces expansion of antigen specific clones via both proliferative 
and antiapoptotic mechanisms. 
Augments production of other cytokines 
Required for differentiation to Th1 and Th2 subsets 
Induces apoptosis of activated T cells via Fas/FasL signaling 
(Activation induced cell death) 
Involved in development of CD4+CD25+ T cells  
CD8+ T cells Induces expansion of antigen specific clones 
Augments cytokine secretion 
Augments cytolytic activity 
Induces proliferation of memory CD8+ T cells 
B cells Enhances antibody secretion 
Initiates immunoglobulin J chain transcription and synthesis 
Promotes proliferation 
NK cells Promotes proliferation 
Augments cytokine secretion 
Enhances cytolytic activity 
 
IL-2R, mediates T-cell growth, and depending on the conditions, also promotes cell survival, 
effector function, and apoptosis (77). IL-2 sensitizes activated T cell to undergo apoptosis or 
activation induced cell death (AICD) by FAS and TNF-dependent pathways (59,118,119). IL-
2 is required for the development, expansion, and/or function of CD4+CD25+ regulatory T 
cells (76). Different functions of IL-2 are summarized in table 4. 
 
1.4.2 IL-2-/- mice develop colitis induced by microflora 
IL-2-/- mice raised in a conventional environment develop a disorder of the hemopoietic and 
immune system characterized by anemia, lymphocytic hyperplasia, progressive loss of B 
cells, disturbances in bone marrow hemopoietic cells, and an inflammatory bowel disease 
(24). One prominent feature of IL-2-/- mice is a massive expansion of lymph nodes and spleen 
due to infiltration of activated T cells, which is consistent with the impaired regulation of 
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homeostatic proliferation (76). IL-2-/- mice develop normally at first 3-4 weeks of age but 
develop severe anemia after this time. 50% mice die from this within 4-9 weeks of age (71). 
The animals which survived develop a progressive colitis first detectable between 6-15 weeks 
of age (89). The histological appearance of this aggressive colitis resembles human ulcerative 
colitis. Colitis is mediated by CD4+ T cells which infiltrate colon and bone marrow to cause 
colitis, anemia and loss of B cells respectively (54). IL-2-/- mice with a BALB/c background 
die in early age, 5 to 6 weeks, from autoimmune reaction against hemopoietic cells, anemia 
(29). 
 
1.4.3 IL-2-/- mice have a dysregulated peripheral T cell response 
At 13 weeks of age of IL-2-/- mice, infiltration of the superficial mucosa by lymphocytes, 
plasma cells, granulocytes and an increased number of mitotic epithelial cells as well as 
ulcerations and crypt abscesses were observed. Horak et al (63) showed that T cells are 
responsible for inflammatory bowel disease in IL-2-/- mice. IL-2-/- mice were bred with RAG-/- 
mice which fail to develop T cell as well as B cell and were free from IBD. In contrast IL-2-/- 
mice bred with JH-/- mice, which lack B cells, develop IBD. It was also shown that CD4+ T 
cells rather than CD8+ T cells which infiltrating the lamina propria are involved in bowel 
inflammation (105). Increased number of αβTCR+CD4+T cells in IEL (Intra epithelial 
lymphocytes) and LPL (lamina propria lymphocytes) of colon from SPF (specific pathogen 
free) IL-2-/- mice were observed (120). IL-2-/- germ free mice showed decrease in the number 
of CD8αα+, particularly γδ+ T cells in IEL (24).  
 
1.4.4 IL-2-/- mice fail to limit autoreactive T cells 
IL-2 sensitizes activated T cells to undergo apoptosis or activation induced cell death (AICD) 
in vitro by upregulation of FAS (CD95) and tumor-necrosis factor receptor (TNFR) 
(59,118,119). It is assumed that AICD is an important mechanism that limits immune 
response by reducing antigen specific T cells. A failure in this mechanism is postulated to be 
associated with lymphoproliferation and lethal autoimmunity in IL-2-/- mice (67). One early 
hypothesis to explain the autoimmunity seen in IL-2-/- mice was impaired negative selection 
of self-reactive thymocytes. CD4+CD25+ T regulatory (TReg) cells develop in the thymus and 
constitute 5-10% of the circulating T cell population in healthy humans and mice. They 
potently inhibit T cell proliferation in vitro and suppress the autoreactive T cells in vivo (76). 
The evidence for this hypothesis has come from some recent findings. The number of TReg 
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cells are markedly reduced in mice that are deficient in IL-2, IL-2 receptor or a downstream 
signaling molecule for IL-2, STAT5 (12). Administration of IL-2 or IL-2 producing cells to 
IL-2-/- mice restores the production of TReg cells and lymphoid homeostasis (1,32,51). IL-2 is 
required for both thymic development and peripheral expansion /maintenance of Treg cells 
(76). IL-2 promotes TReg cell growth and suppressor function in vitro (110-112,114).  
 
1.4.5 B cell development and survival are disturbed in IL-2-/- mice. 
IL-2 plays an important role during an immune response by stimulating antigen-activated B 
lymphocytes to progress through the cell cycle and to differentiate into antibody secreting 
cells (115). IL-2-/- mice initially contain normal numbers of B and T lymphocytes. In older 
mice, the lamina propria of inflamed colons contains elevated levels of T cells, as well as B 
cells, suggesting that both T and B cells are spontaneously activated in the colonic immune 
response (89,98). In addition, anti-colon antibodies are regularly detected in the serum of    
IL-2-/- mice, and these antibodies have been postulated to be involved in causing bowel 
disease (89,108). Together, these observations suggest that in association with T cells, B cells 
and their autoantibody products may be important for the development of bowel disease in IL-
2-/- mice. It was assumed that B cell response against autoantibodies is responsible for IBD 
development (89). To determine the role of B cells in colitis development in IL-2-/- mice,    
IL-2-/- mice were bred with JH-/- mice (these mice possess no mature B cells). There was an 
improvement in anemia in IL-2-/-, JH-/- mice compared to IL-2-/- mice but there was similar 
onset and severity in wasting disease (63). So from above data it was clear that activated B 
cells against autoantibody are not crucial for IBD development. But there is a progressive loss 
of mature B cells in IL-2-/- mice with IBD progression. Schultz et al (101) showed that the 
level of immunoglobulins at mucosal sites and the number of peripheral B lymphocytes in 
mesenteric lymph nodes dramatically decrease over time in specific pathogen free (SPF) and 
germ free (GF) IL-2-/- mice. The same group later showed that B lymphocyte depletion in   
IL-2-/- mice is mainly caused by disrupted B cell development in the bone marrow (99). 
 
1.4.6 Change in cytokine environment in intestine precedes IBD in IL-2-/- mice 
IL-2-/- mice raised under conventional conditions showed higher expression of cytokines, e.g. 
IL-1α, IL-1β, IL-6, TNF-α, IFN-γ, and IL-10 in colon compared to wild type. Cytokine 
profile starts to change at the age of 10 days and this shift in cytokine pattern persists up to 
late age and pronounces with time. In contrast there was a weak TGF-β1 expression in 
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colonic tissue of WT mice compared to IL-2-/- mice. IL-4 was not significantly expressed in 
intestinal tissue of either IL-2-/- mice or wild type mice (3).  
 
1.4.7 Intestinal microflora triggers IBD in IL-2-/- mice 
Splenomegaly, lymphoadenopathy, anemia and inflammatory bowel disease are all 
characteristic disorders displayed by IL-2-/- mice. But IL-2-/- mice raised under germ free 
conditions are shown free of IBD (24,89) even though these mice showed lymphocytic 
hyperplasia affecting hemopoietic, lymphoid and other organs. Lymphocytes infiltration were 
seen in lung, pancreas and kidneys (24). Enterocolitis in IL-2-/- mice is due to an abnormal 
immune response in the mucosa to the intestinal bacteria (24). In contrast Schultz et al (101) 
showed that mild delayed focal gastrointestinal inflammation in GF IL-2-/- mice starts at 13 
weeks of age. They hypothesized nonviable luminal bacterial fragments present in food play a 
role in the gastrointestinal inflammation in GF IL-2-/- mice. Another group also hypothesized 
a role of food antigen for a mild focal inflammation at 33 wk of age associated with a slight 
increase in Th1 cytokines in GF IL-2-/- mice (120).  
But despite this mild focal delayed gastrointestinal inflammation in GF IL-2-/- mice, IL-2-/- 
mice raised under conventional conditions showed rapidly progressing intestinal inflammation 
characterized by mucosal hyperplasia and massive infiltration of the lamina propria with 
mononuclear cells (101).  
 
1.4.8 Different strains of commensals have different capacity of colitis induction in 
IL-2-/- mice 
Normal intestinal flora comprises 400 different species, some of them are beneficial to the 
host and others cause harm in certain clinical settings. So it is possible that not all bacterial 
strains present in the microflora are responsible for colitis development in IL-2-/- mice. 
Waidmann et al (121) showed this by colonizing IL-2-/- mice exclusively with one strain of E. 
coli, named E. coli mpk or B. vulgatus, strains isolated from the fecal flora of SPF IL-2-/- 
mice. IL-2-/- mice were also co colonized with both bacteria or colonized with a known 
probiotic bacteria, E. coli Nissle 1917 (56,86). Only E. coli mpk was able to cause colitis in 
IL-2-/- mice. In contrast B. vulgatus colonized mice were colitis free and it was also able to 
inhibit E. coli mpk induced colitis in IL-2-/- mice (121). 
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1.5 Objective and goals 
 
Among different factors the microflora plays a role in IBD development as well as in colitis 
model IL-2-/- mice. Gnotobiotic IL-2-/- mice revealed different colitogenic potential of 
different species of the microflora. Therefore we investigated how different commensal 
bacteria modulate the immune response of DC and T cells. We wanted to generate hypothesis 
which might explain how B. vulgatus may prevent E. coli mpk triggered colitis development. 
Furthermore by Affymetrix Gene Chip oligo microarray high expression of adipsin, 
adiponectin etc. was found to be associated with colitis prevention (unpublished data kindly 
provided by a colleague from our group, Oliver Bechtold). The cellular source of this factors 
in the intestine was also investigated.  
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2 Materials and Methods 
 
2.1 Molecular biology methods  
 
2.1.1 RNA Isolation 
All materials used in the RNA isolation process were RNase free. The working place was 
cleaned with ‘RNA away’ (Molecular bio products, CA USA). Cells were dissolved in Trizol 
(Invitrogen, Karlsruhe, Germany) according to manufacturers instructions. 200 µl Chloroform 
(Merck, Darmstadt, Germany) was added to the cell samples and were mixed well. Then the 
trizol-chloroform mix was transferred to a precentrifuged Phase Lock Gel (PLG) tube 
(eppendorf, Hamburg, Germany) and centrifuged at 14000 g, 5 minutes at room temperature. 
The upper aqueous layer was transferred to a 2 ml microfuge tube and 500 µl isopropanol 
(Merck, Darmstadt, Germany) was added (1: 0.75). The tubes were shaken and centrifuged at 
12000g for 10 minutes at 4°C. Then the supernatants were discarded, carefully washed with 
70% ethanol (Merck, Darmstadt, Germany) and then the pellet was dried at 37°C for 1-5 
minutes until it turned to viscous. The pellet was dissolved in 10-50µl of DEPC treated water 
(Ambion, UK) and kept at –80°C before further use. The concentration of RNA was estimated 
by Spectral photometer (Ultrospec 3000, Amarsham Pharmacia biotech, Freiburg, Germany) 
at 260 nm wavelength. 
 
2.1.2 Preparation of cDNA  
cDNA was prepared using kit (Invitrogen, Karlsruhe, Germany) with small modifications. 1µl 
of oligo dT primer was added to 5-10 μg RNA, shortly spinned and incubated at 65°C heat 
block (Thermomixer, eppendorf, Hamburg, Germany) for 10 minutes. The samples were 
incubated on ice for 1 minute; 10µl ‘master mix’ was added to each microfuge tube and 
gently mixed with pipette. The samples were spinned down at 4°C and incubated at 50°C for 
1 hour. The Master mix was prepared by adding 4µl 5xfirst strand buffer, 2µl 0.1M DTT, 2µl 
of dNTP mix (10mM each dATP, dGTP, dCTP and dTTP at neutral pH), 1µl RNase OUTTM 
(recombinant RNase inhibitor) and 1µl of SuperScript III reverse transcriptase (200 units/µl). 
After one hour incubation the reaction was stopped by incubating the samples at 70°C for 15 
minutes. cDNA were diluted 1:10 with DEPC treated water and stored at –20°C before further 
use. 
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2.1.3 Quantification of specific messenger RNA by Taqman PCR 
Quantification of adipsin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene 
expression in adipocyte cell line was performed by Taqman real time reverse-transcription 
(RT)-polymerase chain reaction using Assays on demand (Applied Biosystems, Darmstadt, 
Germany) and the TaqMan System (Applied Biosystems, Darmstadt, Germany) according to 
the manufacturer’s instructions 
Real-time RT-PCR was carried out in duplicate in 96-well format on a GeneAmp 5700 
Sequence detection System (Applied biosystems/Applera, Darmstadt, Germany). Each 20 μl 
reaction contained 10μl target gene specific Assay-on-Demand Gene Expression Assay Mix 
(including primers and dye-labeled hybridization probes, Applied Biosystems), 4 μl PCR 
grade water and 5 μl cDNA. Thermal cycling conditions for all reactions were as follows: 2 
minutes at 50°C, 10 minutes at 95°C, then 40 cycles of 15 seconds at 95°C and 1 minute at 
60°C. The standard curve method was used for semiquantitative data analysis, whereas ten 
fold dilutions of pooled cDNA from all samples were used as standards. Data were 
normalized by dividing the values of target gene by the values of the housekeeping gene 
GAPDH. 
 
2.2 Microbiology methods 
 
2.2.1 Bacteria used  
In this study two non-pathogenic E. coli strains, E. coli mpk and E. coli Nissle and an 
aneorobic bacteria strain, Bacteroides vulgatus were used. E. coli mpk and B. vulgatus were 
isolated from the fecal flora of specific pathogen-free (SPF) IL-2-/- mice (120). E. coli Nissle 
1917 (Mutaflor,-Ardeypharm, Herdecke, Germany) is a known probiotic and effective in 
maintaining remission in ulcerative colitis. 
 
2.2.2 Overnight culture of bacteria 
Work with bacteria was done under sterile conditions. E. coli mpk was cultured in LB media 
overnight at 37°C with continuous shaking (200 rpm). For infection assays log phase bacteria 
were used. B. vulgatus was cultured in BHI media under aneorobic condition at 37°C for 48 
hours. Bacterial suspension was centrifuged at 4000g and washed twice with PBS. 
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Table 5: Medium for bacteria culture 
Media LB-Medium BHI (brain heart infusion) medium 
Contents Trypton (10 g) 
Yeast extract (5 g/l) 
NaCl 5 g/L 
pH 7.0 ± 0.2 
BHI-Powder (37 g/L) 
pH 7.4 
 
2.2.3 Preparation of cryostock 
For long time storage of bacteria, bacteria cryostocks containing LB/BHI medium with 20% 
glycerol were prepared and stored at –80°C  
 
2.2.4 Heat killed bacteria preparation 
E. coli mpk was cultured overnight and subcultured in 100 ml LB media at 1:100 according to 
bacterial culture protocol described before. B. vulgatus was cultured in 100 ml BHI medium 
for 2 days according to protocol described above. Bacteria was centrifuged at 4000g, 4°C for 
5 minutes, washed twice in PBS (Invitrogen, Karlsruhe, Germany) and 50µl of bacterial 
suspension was removed for determination of colony forming unit (CFU). The bacterial 
suspension was incubated at 80°C for 10 minutes and then kept on ice for 10 minutes. Heat 
killed bacterial suspension was centrifuged at 4000g, 4°C for 5 minutes and then resuspended 
in PBS (Invitrogen, Karlsruhe, Germany), and stored at –80°C until further use. 
 
2.2.5 Counting viable bacteria by colony forming unit 
Serial dilution of bacterial suspension was done; equal amount from last four dilutions was 
platted on agar plate and incubated at 37°C. Bacterial colonies formed on the plate were 
counted and the concentration of viable bacteria was calculated. 
 
2.2.6 Preparation of bacterial culture supernatant 
Bacteria from cryostock were grown overnight (B. vulgatus was grown two days) in cell 
culture media with supplements. Bacteria were centrifuged at 4000g for 10 minutes; 
supernatants were harvested and filter sterilized (0.20 μm, Sartorius AG, Goettingen, 
Germany). Supernatant was aliquoted, stored at –20°C until further use.   
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2.2.7 Estimation of protein content by pierce protein estimation method 
Protein estimation was done according to instruction from manufacturer (BCA protein 
estimation kit, Pierce, USA). In 96-well plate (Greiner, Nuertingen, Germany) 10μl sample or 
standard (Bovine serum albumin) protein solution was incubated with Pierce reagent at 37°C 
for 30 minutes. Protein concentration was determined relative to standard at 562 nm. 
 
2.3 Protein analysis 
 
2.3.1 Analysis of protein secretion by enzyme linked immunosorbent assay (ELISA) 
To determine the cytokine concentration in the cell culture supernatant, ELISA was done with 
standard protein, primary antibody, biotinylated secondary antibody and detection kit 
(OptEIA ELISA set, Becton Dickinson Heidelberg, Germany) according to their instruction.  
IFN-γ ELISA was done as described previously (120). Briefly 96-well Microtiter plate, round-
bottom (Greiner, Nuertingen, Germany) was coated overnight using 50µl of anti-IFN-γ 
monoclonal antibody (10µg/ml, clone AN18), next day was washed 3 times with 150 µl PB 
buffer (1xPBS with 0.05% Tween 20, Sigma-Aldrich, Taufkirchen, Germany) and then 
blocked at 37°C with 150 µl/well same buffer. After 1 hour the plate was again washed as 
before, 50µl sample/ standard was pipetted and incubated at 4°C overnight. Recombinant 
murine IFN-γ (from Bender, Vienna, Lot: M3-RD48) was used as standard for a concentration 
range from 0 to 80 U/ml. At next day plate was washed and incubated with biotinylated 
secondary antibody (2µg/ml rat anti mouse-IFN hybridoma R46A2 in PBS) for 1 hour at 
37°C. Plates were washed again, incubated with 50 µl/well of a solution containing 
streptavidin and biotinylated alkaline phosphatase (DAKO, Denmark) for 45 minutes at 37°C. 
Then, after washing 50µl/well substrate solution (1 mg/ml p-nitrophenyl-phosphate from 
Sigma, St Louis, Missouri, USA in Carbonate buffer) was added and optical density was 
measured by ELISA reader (Sunrise, Tecan, Crailsheim, Germany) at 405 nm. Concentrations 
of IFN-γ protein were calculated on the basis of an IFN-γ standard curve and linear 
regression. The lower limit of detection was 1.0 ng/ml. 
2.3.2 Analysis of protein expression by Immunohistology 
Colon samples were frozen in tissueTec and sectioned in 5µm width for immunohistology for 
adipsin. For cell culture samples, preadipocyte cells cultured and stimulated on coverslips 
were used for immunohistology. Before fixation samples were washed twice with PBS and 
fixed with 3.75% PFA for 15 minutes at RT. Cells were washed twice with PBS and 
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permeabilized with Triton-X (0.1% sodium citrate and 0.1% Triton X100, Sigma-Aldrich, 
Taufkirchen, Germany), for 2 minutes at RT, for tissue samples 5 minutes at RT. Again 
washed and incubated 40 minutes with H2O2 mix (0.2 ml 30% H2O2 in 11.8 ml methanol 
absolute) at RT (tissue sections were incubated for 10 minutes). Nonspecific binding of 
antibody to Fc receptor was blocked by incubating with Fc block (purified anti-mouse 
CD16/CD32, BD pharmingen, Becton Dickinson Heidelberg, Germany) for 40 minute at RT 
(tissue sections were incubated 20 minutes). Anti-adipsin antibody (P-16, Santa Kruz, USA) 
was added and incubated for 2 hours at RT. Coverslips were washed twice with PBS 
(Invitrogen, Germany) and incubated with biotin labeled secondary antibody (bovine anti goat 
IgG, Santa Kruz, USA) in 1:250 dilution for 1 hour at RT in a humid chamber (for tissue 
sections antibody was diluted 1:100). After incubation with secondary antibody coverslips / 
tissue sections were washed twice with PBS and incubated with streptavidin HRP detection 
system (Invitrogen, Karlsruhe, Germany) according to the manufacturers instruction for 5 
minutes at RT, washed and incubated with freshly prepared substrate solution, DAB-solution 
(Di amino benzidine tetrahydro chloride, Applichem, Darmstadt, Germany), analyzed at 
microscope the formation of brown color and then reaction was stopped with water flow.  
Hemalaon counter stain was performed, coverslips / tissue sections were covered with Aqua 
Tex, analyzed by Microscope (Axiovert200) and photographed by Axiocam HR both from 
Carl Zeiss Vision GmbH, Munich, Germany. 
 
2.4 Cell culture methods 
 
2.4.1 Isolation and culture of BMDC 
Bone marrow cells from C57BL/6x129Sv mouse (provided by C. Kirschning, were 
maintained under specific pathogen-free conditions in our breeding facility) were isolated and 
cultured according to Lutz et al (61) with small modifications. Femur and tibia were cut out 
from mouse, muscles were removed from bone by rubbing with isopropanol on tissue paper. 
Then two sides of the bone were cut down by sterile scissors and bone marrow was flushed 
out. Cell clumps were broken by repeated pipetting and then centrifuged at 400g for 5 minutes 
at room temperature, washed twice and finally the cell pellet was resuspended in complete DC 
media. 2x106 cells were seeded in 100 mm bacteriological petri dishes (Greiner, Nuertingen, 
Germany) in 10 ml complete DC media. At day 3, 10 ml fresh DC media was added to each 
petri dish. At day 6, 10 ml of cell suspension was removed from each plate, centrifuged at 
400g for 5 minutes at room temperature, cell pellet was resuspended in 10 ml fresh complete 
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DC media and given back to petridishes again. At day 8, dendritic cells were harvested and 
used for stimulation / infection.   
Culture media for BMDC 
RPMI 1640 Biochrom, Berlin, Germany 
10% Fetal Calf Serum (inactivated at 37°C  
for 30 minutes)    
Sigma-Aldrich, Taufkirchen, Germany 
Penicillin (100 U/ml) Biochrom, Berlin, Germany 
Streptomycin (100 μg/ml) Biochrom, Berlin, Germany 
L-Glutamin (2 mM) Gibco BRL, Eggenstein, Germany 
2-Merceptoethanol (0.5 mM) Sigma-Aldrich, Taufkirchen, Germany 
Non-essential amino acids  Biochrom, Berlin, Germany 
GM-CSF 200 U/ml GM-CSF (produced by mouse 
myeloma strain P3X63) 
 
2.4.2 Stimulation of BMDC 
At day 8 non-adherent cells were harvested, centrifuged at 400g for 5 minutes at room 
temperature, washed twice with PBS (Invitrogen, Germany) and then resuspended in 
antibiotic free complete DC media. 1x106 DCs were seeded per well of 24 well plates 
(Beckton Dickinson Labware, France) to measure cytokine secreted by DC at different 
stimulations by ELISA and to collect supernatant for T cell stimulation. 1x106 DCs were 
seeded per 100 mm bacteriological petri dish (Greiner, Nuertingen, Germany) to investigate 
activation of DC by flow cytometry (FACS Calibur, Becton Dickinson, Heidelberg, 
Germany). For infection of DC with viable bacteria antibiotic free DC media was used. DC 
were infected with different MOI of bacteria (0.01-1) for one hour, bacteria were killed by 
gentamicin (ICN, USA) and then incubated for additional 23 hours. DC were also stimulated 
with cytokine, cell culture supernatants etc. in ‘DC complete media’ with antibiotics. Cells 
supernatants were stored at –20°C to perform ELISA to quantify IL-12p70, TNF-α, IL-10 and 
IL-6. For T cell stimulation, dendritic cell supernatant were filter sterilized with 0.20 µm filter 
(0.20 μm, Sartorius AG, Goettingen, Germany) and stored at –20°C. 
 
2.4.3 Analysis of activation and maturation of DC  
Activation and maturation of DC was analyzed by staining surface marker of DC with PE 
conjugated anti-mouse CD11c, clone HL3 (Armenian Hamster IgG1, λ), FITC conjugated 
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anti-mouse CD80, clone 16-10A1 (Armenian Hamster IgG2, κ), FITC conjugated anti-mouse 
CD86, clone GL1 (Rat IgG2a, κ), FITC conjugated anti-mouse I-A/I-E, clone 2G9 (Rat IgG2a, 
κ) and FITC conjugated anti-mouse CD40, clone 3/23 (Rat IgG2a,κ). All antibodies used here 
were purchased from Becton Dickinson, Heidelberg, Germany. 
 
2.4.4 Isolation of T cells from spleen 
Spleen of stimulated or transgenic mice was removed. Splenocytes were prepared by 
homogenization of spleen, passing through a steel-sieve. Cells were centrifuged at 400g for 5 
minutes and resuspended in 0.15 M NH4Cl (pH 7.2) and incubated for 1 minute for 
erythrocyte lysis. Splenocytes were washed three times with HBSS (Biochrom, Berlin, 
Germany) and resuspended in cell culture media.  
Culture media for T cells 
RPMI 1640 Biochrom, Berlin, Germany 
10% Fetal Calf Serum (inactivated t 37°C  
for 30 minutes)    
Sigma-Aldrich, Taufkirchen, Germany 
Penicillin (100 U/ml) Biochrom, Berlin, Germany 
Streptomycin (100 μg/ml) Biochrom, Berlin, Germany 
L-Glutamin (2 mM) Gibco BRL, Eggenstein, Germany 
2-Merceptoethanol (0.5 mM) Sigma-Aldrich,Taufkirchen, Germany 
Non-essential amino acids  Biochrom, Berlin, Germany 
Sodium pyruvate (1mM) Biochrom, Berlin, Germany 
 
2.4.5 Purification of naïve CD4+ T cells 
DO11.10 mice transgenic for an ovalbumin323-339 specific TCRαβ obtained from own 
breeding were used as a source of antigen specific T-cells (44). Splenocytes were prepared 
according to protocol explained before. Splenocytes were enriched for T cells by Ficoll 
density gradient centrifugation. Splenocytes were taken in 5 ml T cell complete culture media, 
3 ml Ficoll 1:1 (1 part Ficoll 1.077kg/l, 1 part Ficoll 1.090kg/l, Sigma-Aldrich, Taufkirchen, 
Germany) was added carefully by Pasteur pipette (WU, Mainz, Germany) to the bottom of the 
tube, underneath the cell suspension and centrifuged at room temperature, 1000g for 20 
minutes without break. The interphase of two layers was taken out carefully by Pasteur 
pipette, washed twice with HBSS (Biochrom, Berlin Germany) and cells were resuspended in 
5ml complete T cell culture media. 
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T cells were further enriched by ‘panning’. Petridishes (Greiner, Nuertingen, Germany) were 
coated overnight at 4°C with 15 ml antibody solution containing anti-mouse MHC-II (clone, 
B21-2), anti-mouse CD8 (clone, YST169.4.2.1) and anti- mouse B220 (clone, RA3) each at a 
concentration of 100 μg/ml. Next day, the antibody coated petridish was washed 5 times with 
PBS (Invitrogen, Karlsruhe, Germany), maximum 1x108 cells were taken in 5 ml T cell 
culture medium and incubated at room temperature for 1 hour. Nonadherent cells were 
harvested by washing three times with fresh medium carefully.  
 
2.4.6 Purification of CD4+T cells by Magnetic-activated cell sorting (MACS) 
Naïve CD4+ T-cells were finally purified by magnetic cell sorting kit from Miltenyi Biotec, 
(Bergisch Gladbach, Germany) first performing negative selection of CD4+T cells from 
splenocytes and then by positive selection for CD4+CD62L+ cells according to manufacturer’s 
instruction.  
MACS isolates cells according to their surface marker profile. At first the cells are labelled 
with antibodies conjugated to super-paramagnetic MicroBeads. Then the cells are passed 
through a separation column placed in a strong permanent magnet. The magnetically labelled 
cells are retained in the column, while non-labelled cells pass through. After removing the 
column from the magnetic field, the retained cells are recovered. Two approaches for MACS 
are available: depletion and positive selection. Depletion means that unwanted cells are 
labelled and eliminated from the cell mixture. Whereas in positive selection, the retained cells 
labelled with antibody are isolated. MACS separation columns are used for the separation of a 
broad range of cell subsets. The columns used were MS and LS. The processing capacity of 
MS columns is 107 magnetically labelled cells or up to 2 x 108 total cells. LS Columns are 
useful for the isolation of 107-108 magnetically labelled cells from up to 2 x 109 total cells. 
The column matrix is composed of ferromagnetic spheres covered with a plastic coating, 
allowing fast and gentle selections of cells. All reagents for cell separation by MACS were 
also purchased from Milteny Biotec (Bergisch Gladbach, Germany).  
MACS kits  
CD4+ T cell isolation kit  
CD62L+ Isolation kit  
MS and LS columns  
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Depleting cell subsets by MACS  
CD4+ T cells were purified by depleting other cells present in cell suspension, for example B 
cells, Macrophages, NK cells CD8+T cells, dendritic cells etc. Total 1x107 cells were 
suspended in degassed (degassed by sonification) buffer (0.1% BSA in PBS, 2 mM EDTA, 
pH 7.2) and were labelled with magnetic bid tagged antibodies against their surface markers 
according to manufacturer’s instruction. Labelled cells were applied to the column placed in a 
strong magnetic field. Magnetic bid labelled unwanted cells retained in the column and 
CD4+T cells passed through the column and thus purified. 
 
Positive selection of cell subsets by MACS 
To purify naïve CD4+ T cells (CD4+CD62L+), purified CD4+ T cells were resuspended in 
buffer (0.1% BSA in PBS, pH7.2) and were labelled with magnetic bid tagged anti-CD62L-
antibody (clone, MEL-14) according to manufacturer’s instruction (Miltenyi Biotec, Bergisch 
Gladbach, Germany). Cells were loaded onto equilibrated MS or LS columns and were 
allowed to pass through. Column was washed two times with buffer and was removed from 
the magnet, and cells were eluted from the column by flowing 3 mL of buffer (0.1% BSA in 
PBS, pH 7.2) through them using a plunger. 
 
2.4.7 Stimulation of T cells with differently stimulated/ infected dendritic cell culture 
supernatant 
2.5 x 105 naive T-cells, purified from spleen of DO11.10 mice (44) were cultured in complete 
T cell media at 5% CO2 and 37°C in presence of 5x106 splenic APC (γ-irradiated, 3,000 rads) 
from BALB/c mice (were purchased from Harlan Winkelmann, Borchen, Germany), 0.6 µM 
OVA323-339 peptide (Ovalbumin peptide AA 323-339, Th epitope; D. Palm, Wuerzburg 
University, Germany) and 10% supernatant from BMDC with or without 
stimulation/infection. BMDC supernatant were maintained for the entire period of 
stimulation. The cultures were splitted and the cell number was equalized in each well at day 
3, day 5. Recombinant IL-2 (Biotest pharma, Dreieich, Germany), 20 U/ml was added for last 
4 days of culture. As a control for T cell polarization, T helper type 1 cells were generated by 
adding IL-12 (10ng/ml) and anti IL-4 (10µg/ml, clone, 11B11) and T helper type 2 cells were 
generated by using IL-4 (10ng/ml) and anti-IL-12 (10µg/ml, clone, C 17.8) to T cell culture 
and incubated seven days according to the protocol explained above. The cell cultures were 
stimulated with PMA (50 ng/ml, Calbiochem, UK) and ionomycin (1μg/ml, Sigma-Aldrich, 
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Taufkirchen, Germany). After 2 hours ‘Golgi stop’ (Becton Dickinson, Heidelberg, Germany) 
solution containing Monnensin was added to half of the cell culture. The other half was 
cultured for further 24 hours and the supernatants were collected for assessment of            
IFN-γ  (120), IL-4 and IL-10 (OptEIA ELISA set, Becton Dickinson Heidelberg, Germany) 
by ELISA. Four hours after adding golgi stop to the other half of the cell culture these cells 
were harvested, incubated with Fc-block (Becton Dickinson, Heidelberg, Germany), anti-
FcγII/III receptors (purified 2.4G2 antibody) to block unspecific binding of fluorescent 
labelled antibodies to the Fc receptors of cells. Cells were stained with mouse anti-CD4–
PerCP (clone RM4-5, Becton Dickinson, Heidelberg, Germany). Afterwards the cells were 
fixed and permeabilized with cytofix/cytoperm kit (Becton Dickinson, Heidelberg, Germany) 
according to manufacturer’s instruction and stained with anti-IFN-γ-FITC (Clone, XMG1.2) 
for intracellular cytokine and analysed by flow cytometry. Antibody to IFN-γ was purchased 
from Becton Dickinson, Heidelberg, Germany. 
 
2.4.8 Stimulation of T cells with stimulated/infected dendritic cells  
Naïve CD4+ T cells were isolated from spleen of OT-II mice according to the protocol (2.4.5-
7). Bone marrow derived dendritic cells were generated according to protocol (2.4.1) and 
were used at day 6. BMDC were seeded 3x106 in a specially treated 6-well plate (Beckton 
Dickinson Labware, France) and infected with bacteria at MOI 1. After 1 hour extracellular 
bacteria were killed with gentamicin (ICN, USA), cultured for 24 hours with Ovalbumin 
100µg/ml (Sigma-Aldrich, Taufkirchen, Germany) for last 3 hours. DC were harvested, 
washed and counted before adding to T cell culture. 
2x105 infected / control BMDCs and 8x105 naïve CD4+ T cells were cultured in 24 well 
specially treated plate (Beckton Dickinson Labware, France) for 4 days. At day 4, T cell 
polarization were determined by analyzing cell culture supernatants by ELISA for cytokines, 
IFN-γ, IL-4 and IL-10 secretion (OptEIA ELISA set, Becton Dickinson Heidelberg, 
Germany).  
 
2.4.9 Proliferation assay of T cells by 3[H]-thymidine uptake 
T cells were cultured in round bottom 96-well (Greiner, Nuertingen, Germany) plate. 10µl of 
radioactive tritiated thymidine solution (0.5 ml 3[H]-Thymidine, 37 MBq /ml in PBS + 9.5 ml 
cell culture medium) was added to each well for last 16 hours of incubation period. After this, 
cells were harvested on a filter, dried and analysed by scintillation counter (Top count NXT, 
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Microplate Scintillation and Luminescence counter, A Packard Bioscience company) 
according to instruction from the provider.  
 
2.4.10 Culture method of preadipocyte cell line 3T3-L1 
3T3-L1 cell line (a preadipocyte cell line) which can be differentiated to adipocyte in 
presence of fetal calf serum or presence of insulin, dexamethason and IBMX (iso butyl methyl 
xanthine, Sigma-Aldrich, Taufkirchen, Germany). This cell line was generated from BALB/c 
mice. 
3T3-L1 cell line was cultured in 80 cm2 cell culture flask (Nunc, Roskilde, Denmark) with 
medium explained above at 37°C with 5% CO2 and 95% relative humidity. Cells were splitted 
1:4 at 70% confluence.  
For splitting, 3T3-L1 cells were washed with PBS and treated with Trypsin-EDTA (Gibco 
BRL, Eggenstein, Germany) with 3 minutes incubation at room temparature (3-5ml /80 cm2 
flask). The cell suspension was centrifuged at 400g for 5 minutes, resuspended at complete 
medium and taken one fourth of the cell suspension to one 80 cm2 flask.   
 
Culture media for 3T3-L1 cell line 
D-MEM medium Gibco BRL, Eggenstein, Germany 
5-10% Neonatal Calf Serum (inactivated t 37°C  
for 30 minutes)    
Gibco BRL, Eggenstein, Germany 
Penicillin (100 U/ml) Biochrom, Berlin, Germany 
Streptomycin (100 μg/ml) Biochrom, Berlin, Germany 
L-Glutamin (2 mM) Gibco BRL, Eggenstein, Germany 
 
For long time storage 3T3-L1 cell line was harvested from cell culture flasks using trypsin-
EDTA, cell suspension was centrifuged at 400g for 5 minutes and dissolved in 10% DMSO 
(Merck, Darmstadt, Germany) in FCS. Cell suspension was aliquoted in 1 ml volume in 
‘Nunc cryo tube’ (Nunc, Roskilde, Denmark) and was stored in liquid nitrogen. 
 
2.4.11  Stimulation of preadipocyte cell line 3T3-L1 
3T3-L1 cell line was detatched from the flask by treating with trypsin-EDTA (Gibco BRL, 
Eggenstein, Germany). 1x105 cells were seeded in each well of a 24 well plate in 3T3-L1 
medium (10% NCS) and incubated at 37°C, 5% CO2 and under humid condition. Cell culture 
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media was changed every 2nd day until cells become confluent. After confluence cells were 
kept in 5% NCS containing complete media for two days more before first stimulation was 
done. Stimulation was done for 10 days. Every 2nd day media was changed with fresh media 
and stimulant. 
At day 5 and day 10 of stimulation cells were washed in PBS and fixed with 10% 
formaldehyde at 4°C for 5 hours. Cells were washed with PBS twice and incubated for 2 
hours with Oil Red O (200 µl per well in 24 well plate) at room temperature. Cells were 
destained by washing twice with PBS and then photographed by Microscope (Axiovert200) 
installed with Axiocam HR both from Carl Zeiss Vision GmbH, Munich, Germany. 
 
2.5 Animal experiment methods 
 
2.5.1 Adoptive transfer and stimulation of mice 
DO11.10 (44) splenocytes were prepared as explained before and 2x 106 splenocytes were 
transferred to BALB/c mouse by injecting through tail vein. After 3 days adoptively 
transferred mouse were stimulated with ovalbumin (Sigma-Aldrich, Taufkirchen, Germany) 
and heat killed bacteria intraperitoneally 
 
2.5.2 Analysis of ovalbumin specific T cell proliferation and cytokine expression 
2.5x 105 splenocytes from transferred and then stimulated mice were restimulated with 
different concentration of ovalbumin (20, 100 and 500µg/ml, Sigma-Aldrich, Taufkirchen, 
Germany) or ovapep323-339 (Ovalbumin peptide AA 323-339, Th epitope; D. Palm, Wuerzburg 
University, Germany) in complete T cell culture media in 96 well round bottom plate (Nunc, 
Roskilde, Denmark) for 72 hours. Tritiated thymidine was added to the culture for last 16 
hours. Cells were harvested and 3[H]-thymidine uptake was measured according to protocol 
explained at 2.4.9. 2x 106 splenocytes from transferred and then stimulated mice were also 
restimulated with different concentration of ovalbumin (20,100 and 500µg/ml, Sigma-
Aldrich, Taufkirchen, Germany) to determine the different cytokine expression by ELISA 
after 72 hours of incubation. 
 
2.6 Statistical analysis of results 
Statistical analysis was performed using the paired Student’s t test. P values > 0.05 were 
considered significant. Error bars represent ± SD 
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3  Results 
3.1 E. coli mpk and B. vulgatus differentially modulate DC 
 
3.1.1 Colitogenic E. coli mpk and noncolitogenic B. vulgatus bacteria differentially 
modulate cytokine expression in dendritic cells 
Previous studies showed that colonization with different bacteria modulate colitis 
development in IL-2 deficient mice. Thus monocolonization of IL-2-/- mice with E. coli mpk 
but not B. vulgatus induces colitis (121). In this study we wanted to know if this difference in 
colitis development is related to different DC activation by these bacteria in terms of cytokine 
production and surface marker expression.  
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 Figure 3: Different bacteria induce differential cytokine secretion by dendritic cells. 
Bone marrow derived dendritic cells were infected with different MOI (0.01-1) of E. coli mpk and B. 
vulgatus, extracellular bacteria were killed by gentamicin after 1 hour and cells were cultured for 
additional 23 hours. Cell culture supernatants were analyzed by ELISA for TNF-α, IL-12p70, IL-6 
and IL-10. The results are representative of three independent experiments. Each experiment was done 
in triplicate; error bars represent SD of duplicate. *p<0.05 compared to E. coli mpk.  
 
To assess the effect of different bacteria on dendritic cells, BMDC were infected with E. coli 
mpk and B. vulgatus at different MOI (0.01 to 1). After one hour of infection extracellular 
bacteria were killed by gentamicin and cells were cultured for additional 23 hours. Cell 
supernatants were analyzed for cytokine secretion by ELISA. In addition DC was analyzed 
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for surface markers indicating activation and maturation by flow cytometry. E. coli mpk 
induced secretion of significant amounts of TNF-α, IL-12 and IL-10 upon infection with a 
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Figure 4: B. vulgatus keeps dendritic cells in a semimature/intermediate state. Bone 
marrow derived dendritic cells were cultured with different bacteria at MOI 1 for 1 hour, bacteria were 
killed by gentamicin and cells were cultured for additional 23 hours. After 24 hours cells were 
harvested, stained with anti-CD11c-PE and anti-CD86-FITC or anti-CD11c-PE and anti-MHC-II-
FITC or anti-CD11c-PE and anti-CD40-FITC. Double stained cells were analyzed by flow cytometry. 
Histograms show expression of CD86, MHC-II and CD40 on CD11c+ DC. The results are 
representative of three independent experiments.  
 
MOI of 0.1 (Figure 3). The amounts of TNF-α, IL-12 and IL-10 secretion were further 
increased upon infection with a MOI of 1. Thus, upon infection with a MOI of 1 around 3.5 
ng/ml TNF-α, more than 1.2 ng/ml IL-12 and approximately 500 ng/ml IL-10 were measured. 
In contrast infection of DC with B. vulgatus at a MOI of 1 did not induce significant amounts 
of TNF-α and IL-12. IL-10 was induced by B. vulgatus in DC but at a two fold lower level 
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than upon infection with E. coli mpk. After infection of DC with E. coli mpk at a MOI of 0.01 
more than 1.5 ng/ml IL-6 were secreted. Because an increase in the infection dose did not lead 
to more IL-6 secretion indicating that E. coli mpk at MOI of 0.01 was sufficient to trigger 
maximal levels of IL-6 secretion by DC. In contrast infection with B. vulgatus at MOI of 1 
was necessary to trigger similar high levels of IL-6 secretion than infection with E. coli mpk. 
Furthermore, infection with E. coli mpk led to high expression of CD86, MHC II, and CD40. 
In contrast, B. vulgatus triggered CD86, MHC II, and CD40 expression was much lower 
compared to E. coli mpk infected DC (Figure 4). Taken together the secretion of high levels 
of cytokines and expression of indicated surface markers suggest activation and maturation of 
DC by E. coli mpk. In contrast, the low expression of activation and maturation markers, 
CD86, MHC II and CD40 and the low amounts of cytokines indicate that B. vulgatus does not 
fully activate DC. We termed this phenotypically different DC with intermediate maturation 
as intermediate/semimature DC characterized by impaired cytokine secretion and low 
expression of surface markers.  
 
3.1.2 E. coli mpk induced IL-12 secretion by DC is TLR4 and partially TLR2 
dependent, but IL-6 secretion is unaffected by TLR2 and TLR4 deficiency in 
DC 
Dendritic cells recognize pathogens or molecules from pathogens by toll like receptors (TLR). 
E. coli mpk and B. vulgatus are gram negative rods which contain LPS and also lipoprotein on 
their cell membrane. LPS in association with other molecules binds to TLR4 and lipoprotein 
binds to TLR2 expressed on dendritic cells surface. To assess, whether the E. coli mpk 
induced cytokine secretion by dendritic cells are TLR2 and TLR4 dependent, dendritic cells 
were generated from bone marrow of TLR2-/- mice and TLR4-/- mice as well as from wild 
type mice. These dendritic cells were infected with E. coli mpk and B. vulgatus at MOI 1. 
Extracellular bacteria were killed with gentamicin after one hour and cells were cultured for 
another 23 hours. At 24 hours of culture cell culture supernatants were analyzed for TNF-α, 
IL-12p70, IL-10 and IL-6 secretion by ELISA.  
TNF-α secretion by TLR4-/-DC infected with E. coli mpk was 90% reduced and was 40% 
reduced in DC from TLR2-/- mice compared to DC from wild type mice infected with E. coli 
mpk (Figure 5A). B. vulgatus was unable to induce TNF-α secretion in TLR2-/-, TLR4-/- and 
wild type DC. E. coli mpk induced IL-12 secretion was totally abolished in TLR4-/- DC, and 
reduced to about 50% in TLR2-/- DC compared to wild type DC (Figure 5B). DC from   
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TLR2-/-, TLR4-/- and WT infected with B. vulgatus also showed similar patterns of reduction 
in IL-12 secretion. However, IL-12 secretion was much lower compared to E. coli mpk 
induced secretion of this cytokines by different DCs. IL-10 secretion by DC with infection of 
these two bacteria also depends on TLR2 and TLR4 signalling. E. coli mpk induced IL-10  
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Figure 5: IL-12 induction by DC is TLR2 and TLR4 dependent. Dendritic cells derived 
from bone marrow of wild type, TLR2-/-, TLR4-/- mice were infected with E. coli mpk and B. vulgatus 
at MOI 1 for 1 hour, bacteria were killed by gentamycin and cells were cultured for additional 23 
hours. Cell culture supernatants were analyzed by ELISA for IL-12p70 and IL-6. The results are 
representative of three independent experiments. Each experiment was done in triplicate; error bars 
represent SD of duplicate. *p<0.05 compared to E. coli mpk.  
  
secretion by DC was reduced more than 90% in TLR4-/- DC and about 30% in TLR2-/- DC 
compared to wild type DC (Figure 5D). But B. vulgatus induced IL-10 secretion was reduced 
in both TLR2-/- DC and TLR4-/- DC compared to wild type DC similarly (around 90% 
reduction). E. coli mpk induced similar amount of IL-6 secretion in TLR2-/-, TLR4-/- and wild 
type dendritic cells. Similarly, B. vulgatus triggered IL-6 secretion was comparable in infected 
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DC from TLR2-/-, TLR4-/- and WT mice (Figure 5C). So above data suggest that IL-12,   
TNF-α and IL-10 secretion by DC with E. coli mpk infection depends on TLR4 and partially 
on TLR2 signalling. In contrast, IL-6 secretion by DC was not affected by TLR2 and TLR4 
deficiency. So far it is unclear whether deficiency of both TLR2 and TLR4 leads to B. 
vulgatus or E. coli mpk triggered IL-6 secretion. 
 
3.1.3 B. vulgatus can inhibit E. coli mpk induced TNF-α secretion by dendritic cells 
Different Lactobacillus species modulated DC differently and among them, Lactobacillus 
reuteri was able to inhibit activation of DC with Lactobacillus casei infection (22). 
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Figure 6: Modulation of E. coli mpk induced TNF-α expression in DC by B. vulgatus. 
Dendritic cells were (A) prestimulated with B. vulgatus at different MOI, after 24 hours infected with 
E. coli mpk at MOI 1 and cultured for 1 hour, extracellular bacteria were killed by gentamicin and 
were cultured for additional 23 hours or (B) DC were coinfected with B. vulgatus at different MOI and 
E. coli mpk at MOI 1, cultured for 1 hour, extracellular bacteria were killed by gentamicin and DC 
were cultured for additional 23 hours. Cell culture supernatants were analyzed by ELISA for TNF-α. 
The results are representative of three independent experiments. Each experiment was done in 
triplicate; error bars represent SD of duplicate. *p<0.05 compared to E. coli mpk.  
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Cocolonized IL-2-/- mice with E. coli mpk and B. vulgatus remain healthy whereas 
monocolonized IL-2-/- mice with E. coli mpk develop colitis (121). These studies pointed to a 
possible inhibitory role of B. vulgatus on E. coli mpk mediated immune response. Therefore 
we investigated whether B. vulgatus may suppress E. coli mpk triggered DC activation.  
At first BMDC were infected with E. coli mpk and B. vulgatus at the same time (simultaneous 
stimulation). After one hour extracellular bacteria were killed by gentamicin and cells were 
cultured for additional 23 hours. Cell culture supernatants were analyzed for TNF-α secretion 
by ELISA. B. vulgatus did not inhibit the E. coli mpk induced TNF-α secretion in 
simultaneous infection (Figure 6B). Infection with E. coli mpk alone or infection with both E. 
coli mpk and B. vulgatus induced high TNF-α (1-1.5 ng/ml) secretion by DC. In contrast, if 
dendritic cells were pretreated for 24 hours with B. vulgatus and subsequently infected with E. 
coli mpk and cultured for additional 24 hours, TNF-α secretion by DC was lower compared to 
infection with E. coli mpk alone by DC (Figure 6A). Thus, E. coli mpk alone induced 3ng/ml 
TNF-α secretion by DC whereas DC prestimulated for 24 hours with B. vulgatus at MOI 1 
and then stimulated with E. coli mpk for additional 24 hours induced only 0.5 ng/ml TNF-α. 
However prestimulation of DC with B. vulgatus does not have any effect on E. coli mpk 
induced IL-6 secretion by DC (Figure 7). The prestimulated DC, with B. vulgatus at MOI 1 
and DC without prestimulation both secreted ~1.25 ng/ml IL-6 with further stimulation by E. 
coli mpk.  
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Figure 7: B. vulgatus does not inhibit E. coli mpk induced IL-6 expression in DC. 
Dendritic cells were prestimulated with B. vulgatus at different MOI (0.01-1), after 24 hours infected 
with E. coli mpk at MOI 1. After 1 hour extracellular bacteria were killed by gentamicin and cells 
were cultured for additional 23 hours. Cell culture supernatants were analyzed by ELISA for IL-6. The 
results are representative of three independent experiments. Each experiment was done in triplicate; 
error bars represent SD of duplicate. *p<0.05 compared to E. coli mpk.  
Results   44
These data indicate that B. vulgatus prestimulated DC can no longer be activated by E. coli 
mpk to induce TNF-α secretion. However, prestimulation of dendritic cells with B. vulgatus 
has no effect on E. coli mpk induced IL-6 secretion by DC. 
 
3.1.4 B. vulgatus inhibits E. coli mpk induced activation and maturation of DC 
Prestimulation of DC with B. vulgatus inhibits E. coli mpk induced cytokine secretion by DC 
(revealed from previous study). To investigate if B. vulgatus has the same inhibitory effect on 
E. coli mpk induced expression of surface markers for activation and maturation as well, 
BMDC were  stimulated with B. vulgatus  at MOI 1 for 24 hours  and then were  restimulated  
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Figure 8: B. vulgatus can inhibit E. coli mpk induced activation and maturation of DC. 
Dendritic cells were prestimulated with B. vulgatus at MOI 1, after 24 hours infected with E. coli mpk 
at MOI 1 and cultured for 1 hour, extracellular bacteria were killed by gentamycin and cells were 
cultured for additional 23 hours. Cells were harvested, stained with anti-CD11c-PE and anti-CD80-
FITC or anti-CD11c-PE and anti-CD86 or anti-CD11c-PE and anti-MHC II-FITC. Double stained 
cells were analyzed by flow cytometry. The results are representative of three independent 
experiments. 
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with E. coli mpk at MOI 1. After 1 hour, cultures were treated with gentamicin and were 
incubated for additional 23 hours. Cells were harvested and analyzed for expression of 
CD11c, CD80, CD86 and MHC-II. Diminished expression of activation and maturation 
markers on B. vulgatus prestimulated and then E. coli mpk induced DC was observed 
compared to E. coli mpk infected DC (Figure 8). In E. coli mpk infected DC, the DC 
population with high expression of costimulatory molecules (CD80 and CD86) and MHC II 
were higher compared to B. vulgatus prestimulated then E. coli mpk infected DC. In contrast 
to sequential stimulation of DC, with B. vulgatus (MOI 1) and after 24 hour with E. coli mpk 
(MOI 1), low maturation marker expressing DC population is increased compared to only E. 
coli mpk infected DC. Similar phenotype of DC, low maturation marker expression was also 
observed in case of B. vulgatus infected intermediate/semimature DC. 
 
3.1.5 Recombinant IL-6 or supernatant of DC treated with B. vulgatus can inhibit E. 
coli mpk induced TNF-α secretion by dendritic cells 
It was shown in previous results that E. coli mpk induces TNF-α, IL-12 and IL-6 secretion by 
DC. In contrast B vulgatus induces only IL-6 secretion by DC (Figure 3). Therefore it was 
hypothesized that IL-6 secreted by B. vulgatus treated DCs, in the absence of TNF-α and    
IL-12 primes DC to an intermediate state. This intermediate DC probably is less capable in 
production of proinflammatory cytokines and upregulation of activation and maturation 
markers with further E. coli mpk infection compared to activation with E. coli mpk alone. To 
investigate this hypothesis, immature dendritic cells were prestimulated with different amount 
of supernatant from dendritic cell culture infected with B. vulgatus (SN B. vulgatus) (Figure 
9A) or different concentrations of recombinant IL-6 (Figure 9B) for 24 hours and then 
infected with E. coli mpk at MOI 1. After one hour extracellular bacteria were killed by 
gentamicin and cells were cultured for additional 23 hours. Cell culture supernatants were 
analyzed for TNF-α secretion. Activation and maturation of DCs were also analyzed by flow 
cytometry for the surface markers CD80, CD86 and CD40 (Figure 10). DC which were 
prestimulated with 10% ‘SN B. vulgatus’ and then infected with E. coli mpk were able to 
induce only 1.5 ng/ml TNF-α whereas immature DC infected with E. coli mpk produces 
around 6 ng/ml (Figure 9A). And this reduction further increases with increased dose of 
prestimulation (50% ‘SN B. vulgatus). Similarly, DC primed with IL-6 (2.5 and 5 ng/ml) 
produces less TNF-α (<2 ng/ml) with E. coli mpk infection compared to TNF-α production (6 
ng/ml) by immature DC infected with E. coli mpk alone (Figure 9B). Stimulation with IL-6 or 
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‘SN B. vulgatus’ prior to infection with E. coli mpk also led to a lower expression of the 
costimulatory molecules CD80, CD86 and CD40 compared to infection with E. coli mpk 
alone. From previous data (Chapter 3.1.1) it is known that culture supernatant of B. vulgatus 
infected DC (‘SN B. vulgatus’) contains IL-6. Taken together these findings suggest a crucial 
role of IL-6 in priming DC to an inert state and thus limiting wasting immune response. 
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Figure 9: IL-6 present in B. vulgatus infected DC supernatant inhibits E. coli mpk 
induced TNF-α production by DC. Dendritic cells were prestimulated with (A) different amount 
of supernatant (10% and 50%) from DC culture infected with non-colitogenic B. vulgatus at MOI 1 
(SN B. vulgatus), or (B) with different concentrations of recombinant IL-6 (2.5 & 5 ng/ml). After 24 
hours cultures were infected with E. coli mpk at MOI 1 and incubated for 1 hour, extracellular bacteria 
were killed by gentamicin and were cultured for additional 23 hours. Cell culture supernatants were 
analyzed by ELISA for TNF-α. The results are representative of three independent experiments. Each 
experiment was done in triplicate; error bars represent SD of duplicate. *p<0.05 compared to E. coli 
mpk.  
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Figure 10: IL-6 present in B. vulgatus infected DC supernatant inhibits E. coli mpk 
induced activation of DC. Dendritic cells were prestimulated with (A) 50% supernatant from DC 
culture infected with B. vulgatus at MOI 1(SN B. vulgatus), or (B) with recombinant IL-6 (5 ng/ml), 
after 24 hours infected with E. coli mpk at MOI 1, cultured for 1 hour, extracellular bacteria were 
killed by gentamicin and cells were cultured for additional 23 hours. Cells were harvested, stained 
with anti-CD11c-PE and anti-CD80-FITC or anti-CD11c-PE and anti-CD86-FITC or anti-CD11c-PE 
and anti-CD40-FITC. Double stained cells were analyzed by flow cytometry. The results are 
representative of three independent experiments.  
 
3.1.6 Neutralization of IL-6 in B. vulgatus treated dendritic cell supernatant abolishes 
its inhibitory capacity 
To further verify that pretreatment of DC with IL-6 in the supernatant of B. vulgatus treated 
DCs and not other factors are crucial to prevent the E. coli mpk triggered cytokine secretion 
and expression of surface markers, IL-6 mediated effects were neutralized by adding 
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antibodies against IL-6. Dendritic cells were prestimulated with this supernatant for 24 hours 
and then infected with E. coli mpk. After one hour cultures were treated with gentamycin and 
incubated for additional 23 hours. Cell culture supernatants were analyzed for TNF-α  by 
ELISA (Figure 11) and cells were analyzed by flow cytometry for expression of the activation 
marker MHC-II (Figure 12). DC primed with ‘SN B. vulgatus’ induced less TNF-α (~50% 
reduction) after infection with E. coli mpk compared to direct treatment with E. coli mpk. 
 
                   
0
2
4
6
TN
F-
α (
ng
/m
l)
*
SN B. vulgatus
α-IL-6 (10 µg/ml)
E. coli mpk MOI
50% 50% 50%
1
+... ... ......
...
TN
F-
α (
ng
/m
l)
 
 
Figure 11: Neutralization of IL-6 present in B. vulgatus infected DC supernatant 
abolishes its ability to inhibit E. coli mpk induced TNF-α secretion in DC. Dendritic cells 
were prestimulated with different percentages of supernatant from DC cultures infected with non-
colitogenic bacteria B. vulgatus at MOI 1 (SN B. vulgatus) with or without 10µg/ml anti-IL-6. After 
24 hours cultures were infected with E. coli mpk at MOI 1, cultured for 1 hour, extracellular bacteria 
were killed by gentamicin and cells were cultured for additional 23 hours. Culture supernatants were 
harvested and analyzed for TNF-α by ELISA. The results are representative of three independent 
experiments. Each experiment was done in triplicate; error bars represent SD of duplicates. *p<0.05  
 
When IL-6 was neutralized in ‘SN B. vulgatus’ and DC was pretreated with it, the treatment 
with the supernatant could no longer prevent subsequent induction of TNF-α secretion by E. 
coli mpk. In addition the decreased expression of MHC II molecules upon E. coli mpk 
stimulation due to the pretreatment of DC with ‘SN B. vulgatus’ was restored by 
neutralization of IL-6 in it. These data indicate that IL-6 in the supernatant of B. vulgatus 
treated DC is crucial to prevent the stimulation by E. coli mpk which include TNF-α level and 
MHC II expression. These data further suggest the role of IL-6 in modulating the function of 
DC. 
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Figure 12: Neutralization of IL-6 present in B. vulgatus infected DC supernatant 
abolishes its capacity to inhibit E. coli mpk induced activation of DC. Dendritic cells were 
prestimulated for 24 hours with supernatant from DC culture infected with non-colitogenic bacteria B. 
vulgatus at MOI 1 (SN B. vulgatus) with or without 10µg/ml anti-IL-6. Cultures were then infected 
with E. coli mpk at MOI 1. After 1 hour, extracellular bacteria were killed by gentamicin and cells 
were cultured for additional 23 hours. Cells were harvested, stained with anti-CD11c-PE and anti-
MHC-II-FITC. CD11c+ cells were analyzed by flow cytometry for MHC-II expression.  
 
 
 
3.2 Colitogenic E. coli mpk causes Th1 polarization in vitro. 
3.2.1 Supernatant of DC infected with E. coli mpk polarizes naïve T cells to Th1 
From previous study (Chapter 3.1.1) it was clear that E. coli mpk and B. vulgatus 
differentially modulate DC activation. Also IL-2-/- mice develop Th1 driven colitis triggered 
by microflora (3). IL-2-/- mice monocolonized with E. coli mpk develop colitis with high 
expression of IFN-γ in colonic tissue whereas B. vulgatus monocolonized IL-2-/- mice do not 
develop colitis (121). Therefore we investigated if E. coli mpk stimulated DC factors are able 
to cause Th1 polarization and if there is any difference between E. coli mpk and B. vulgatus in 
this action. Naïve T cells were purified from spleen of DO11.10 mice. DO11.10 mice have 
transgenic CD4+ T cells that recognize ovalbumin (specifically the peptide fragment from 323 
to 339 amino acid of ovalbumin protein) as antigen (44). Naïve T cells from DO11.10 mice 
were cultured with irradiated splenocytes from BALB/c mice as antigen presenting cells 
(APC) and 0.6µM OVA-peptide323-339 as antigen with 10% infected or uninfected dendritic 
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cell supernatant (cultured as explained at Chapter 3.1.1). The cells were splitted at day 3 and 
day 5 with addition of IL-2 for the last 4 days. At day 7 supernatants of cultured cells were 
analyzed for IFN-γ and IL-4 by ELISA and also cells were analyzed for the intracellular   
IFN-γ present in CD4+ T cells. T cells stimulated with APC, OVA-peptide323-339 as antigen in 
addition of supernatant from untreated DC produced low amounts of IFN-γ (<10 ng/ml) and 2 
ng/ml IL-4. T cells stimulated with APC, OVA-peptide323-339 in addition to E. coli mpk 
infected dendritic cell supernatant induced significantly higher IFN-γ production (~100 ng/ml)  
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Figure 13: Supernatants from DC infected with E. coli mpk or B. vulgatus differentially 
polarize T-cells. Naïve CD4+ T-cells from DO11.10 mice were incubated with Ova-323-339 peptide 
and irradiated splenocytes from BALB/c mice in the presence of 10% supernatant from uninfected DC 
(SN control) and SN from DC infected with E. coli mpk (SN E. coli mpk) or B. vulgatus (SN B. 
vulgatus) bacteria. (A). After 7 days levels of IFN-γ and IL-4 of these culture supernatants were 
determined by ELISA and (B)Intracellular IFN-γ in T-cells were determined by flow cytometry. The 
results are representative of three independent experiments. Each experiment was done in duplicates; 
error bars represent SD of duplicates. *p<0.05 compared to E. coli mpk.  
 
by antigen specific T cells compared to B. vulgatus infected DC supernatant (~20ng/ml) as 
shown by ELISA of culture supernatant (Figure 13A) and intracellular IFN-γ staining (25% vs 
5.8%) and then detection by flow cytometry (Figure 13B). In contrast, ‘SN B. vulgatus’ 
induced some IL-4 production in T cells which was absent in supernatant E. coli mpk induced 
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T cells. So these data suggest that E. coli mpk induced secreted factors from DC are able to 
polarize naïve T cells to Th1 cells. However the supernatant of immature DC culture induced 
higher IL-4 secretion by T cells than B. vulgatus infected DC supernatant.  
 
3.2.2 Th1 polarization needs TLR4 and TLR2 signaling in dendritic cells 
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Figure 14: Th1 polarization by differently infected DC supernatant is dependent on 
TLR4 and TLR2. Naïve CD4+ T-cells from DO11.10 mice were incubated with Ova-323-339 peptide 
and irradiated splenocytes from BALB/c mice in the presence of 10% supernatant from uninfected DC 
(SN PBS) and SN from DC infected with colitogenic E. coli mpk (SN E. coli mpk). DC was generated 
here from wild type, TLR2-/- and TLR4-/- mice. After 7 days supernatants of these T cell cultures were 
harvested. Intracellular IFN-γ in T-cells was determined by flow cytometry (A), and the levels of IFN-
γ in supernatant (B) were determined by ELISA. The results are representative of three independent 
experiments. Each experiment was done in duplicates; error bars represent SD of duplicates. *p<0.05 
compared to E. coli mpk.  
 
 
Before (Figure 5) it was shown that TNF-α and IL-12 secretion by dendritic cells depends on 
TLR4 and TLR2 signaling. To assess if the Th1 polarizing capacity of E. coli mpk is also 
TLR2 or TLR4 dependent, DCs were generated from bone marrow of TLR2-/-, TLR4-/- and 
wild type mice and were infected with E. coli mpk. Cultures were treated with gentamicin 
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after one hour and incubated for additional 23 hours. Cell culture supernatants were filter 
sterilized and used for T cell stimulation. Naïve T cells from DO11.10 mice were cultured 
with irradiated splenocytes from BALB/c mice, ovalbumin323-339 peptide in the presence of 
10% infected or uninfected dendritic cell supernatant as explained before. Cultures were 
splitted on day 3 and day 5 and IL-2 was added for the last 4 days. On day 7 culture 
supernatants were analyzed for IFN-γ by ELISA (Figure 14B) and cells were also analyzed by 
flow cytometry for intracellular IFN-γ in CD4+ T cells (Figure 14A). IFN-γ secretion by T 
cells was reduced to 50% in E. coli mpk infected culture supernatant (SN E. coli mpk) from 
TLR2-/- DC and reduced to basal level in case of SN E. coli mpk from TLR4-/- DC 
stimulation. The same was observed in IFN-γ expression analyzed by flow cytometry. Taken 
together these data indicate that T cell polarization by infected DC factors depends on 
recognition of microbial products by TLR4 and partially by TLR2 on DC.  
 
3.2.3 IL-12 in E. coli mpk infected DC supernatant plays a role in Th1 polarization 
DC primed with foreign antigen or pathogen become activated, secrete cytokines such as    
IL-12 and IL-18 which play a role in T helper cell polarization during T cell activation. To 
investigate if IL-12, IL-18 plays a role in Th1 polarization by secreted factors from DC 
primed with  E. coli mpk, IL-12  and IL-18 were neutralized  in E. coli mpk  infected  DC 
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Figure 15: T cell polarization by infected DC supernatant depends on IL-12 content of 
the supernatant. Naïve CD4+ T-cells from DO11.10 mice were incubated with Ova-323-339 peptide 
and irradiated spleenocytes from BALB/c mice in presence of 10% supernatant from uninfected DC 
(SN PBS) and SN from DC infected with E. coli mpk (SN E. coli) with/ without α-IL-12, α-IL-18 or 
both. After 7 days supernatants of these cultures were harvested and the levels of IFN-γ were 
determined by ELISA. The results are representative of three independent experiments. Each 
experiment was done in duplicate; error bars represent SD of duplicate. *p<0.05 compared to E. coli 
mpk.  
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supernatant and were used to stimulate T cells. Immature BMDCs were infected with E. coli 
mpk for 1 hour, extracellular bacteria were killed by gentamicin and were cultured for 
additional 23 hours. Culture supernatants were filter sterilized. IL-12 and IL-18 in these 
supernatants were neutralized by adding neutralizing antibodies against IL-12 and IL-18 and 
were used in T cell stimulation. 
Naïve T cells from DO11.10 mice were cultured with irradiated splenocytes from BALB/c 
mice, OVA-peptide323-339 and in presence of 10% infected dendritic cell supernatants with/ 
without neutralization of IL-12 or IL-18. Cells were splitted at day 3 and day 5 with addition 
of IL-2 for last 4 days. At day 7 cell culture supernatants were analyzed for IFN-γ production 
by ELISA. There was 90% reduction of IFN-γ secretion by T cells stimulated after IL-12 
neutralization in E. coli mpk infected DC supernatant. IL-18 neutralization had no effect on 
IFN-γ secretion by T cells, (Figure 15). This data suggests an important role of IL-12 which is 
present in DC supernatant stimulated with E. coli mpk for IFN-γ production by T cells and 
thus Th1 polarization. 
 
3.2.4 LPS present in E. coli mpk infected DC supernatant also plays role in Th1 
polarization  
To investigate if LPS present in bacteria infected dendritic cell supernatants is responsible for 
IFN-γ secretion by T cells, LPS in the supernatant was neutralized by polymyxin B. Dendritic 
cells were infected with E. coli mpk or B. vulgatus or stimulated with LPS, cultures were 
treated with gentamicin after 1 hour and incubated for additional 23 hours. Culture 
supernatants were filter sterilized and LPS was neutralized by polymyxin B. Naïve CD4+ T 
cells from DO11.10 mice were cultured with irradiated splenocytes from BALB/c mice, as 
antigen OVA-peptide323-339 with 10% stimulated-DC supernatant with/without LPS 
neutralization for 7 days in presence of IL-2 for last 4 days. LPS neutralization in E. coli mpk 
infected DC supernatant reduced IFN-γ secretion (90%) by T cells upon stimulation and also 
induced some IL-4 secretion by these T cells. In contrast polymyxin treatment of B. vulgatus 
infected DC supernatant has no effect on IFN-γ secretion by T cells, rather the IL-4 secretion 
increases around 2.5 fold by LPS neutralization. LPS stimulated dendritic cell supernatant 
also stimulated less IFN-γ in T cell after LPS neutralization (Figure 16). Therefore, these data 
demonstrates that LPS together with IL-12 plays a role in Th1 polarization by E. coli mpk 
infected DC supernatant. 
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Figure 16: T cell polarization by differently infected DC supernatant is reduced by 
neutralization of LPS from the supernatant. Naïve CD4+ T-cells from DO11.10 mice were 
incubated with Ova323-339 peptide and irradiated spleenocytes from BALB/c mice in presence of 10% 
supernatant from uninfected DC (SN PBS) and SN from DC infected with colitogenic (SN E. coli 
mpk) or non-colitogenic (SN B. vulgatus) bacteria with or without polymyxin B treatment. After 7 
days supernatants of these cultures were harvested and the levels of IFN-γ (Α) and IL-4 (B) were 
determined by ELISA. The results are representative of three independent experiments. Each 
experiment was done in duplicates; error bars represent SD of duplicates. *p<0.05 compared to 
without polymyxin treated counterpart.  
 
3.2.5 Supernatant of B. vulgatus infected DC can inhibit E. coli mpk induced Th1 
polarization 
It was shown earlier (Chapter 3.1.3) that B. vulgatus pretreatment of DC can prevent E. coli 
mpk induced cytokine secretion by DC. So far it was shown that pretreatment of DC with B. 
vulgatus prevents cytokine secretion triggered by E. coli mpk. In addition E. coli mpk treated 
DC supernatant but not B. vulgatus pretreated DC supernatant led to Th1 polarization. 
Therefore we hypothesized that supernatants from DCs pretreated with B. vulgatus and then 
stimulated with E. coli mpk should induce low IFN-γ secretion by T cells upon stimulation. 
To prove this T cells were stimulated with B. vulgatus and E. coli mpk infected DC 
supernatant. In brief, dendritic cells were prestimulated with B. vulgatus for 1 day and then 
infected with E. coli mpk, after one hour cultures were treated with gentamicin and incubated 
for another 23 hours. Culture supernatants were filter sterilized and used for T cell 
stimulation.  Naïve CD4+T  cells purified from spleen of  DO11.10 mouse were  cultured with  
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Figure 17: B. vulgatus can inhibit E. coli mpk induced Th1 polarization. Naïve CD4+ T-
cells from DO11.10 mice were incubated with Ova-323-339 peptide and irradiated splenocytes from 
BALB/c mice in presence of 10% supernatant from uninfected DC (SN Control) and SN from DC 
infected with E. coli mpk (SN E. coli mpk) or B. vulgatus (SN B. vulgatus) or co stimulated 
sequentially with B. vulgatus and then E. coli mpk (SN B. vulgatus, E. coli mpk ). After 7 days 
cultures were harvested. (A) Intracellular IFN-γ in T-cells was determined by flow cytometry and (B) 
the levels of IFN-γ in supernatant were determined by ELISA. The results are representative of three 
independent experiments. Each experiment was done in duplicate; error bars represent SD of 
duplicates. *p<0.05 compared to E. coli mpk.  
 
irradiated splenocytes from BALB/c mice, 0.6µM OVA peptide323-339 in presence of 10% DC 
supernatant. Cultures were splitted at day 3 and day 5 and IL-2 was added for last 4 days. At 
day 7 culture supernatants were analyzed for IFN-γ by ELISA and also cells were analyzed by 
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flow cytometry for the intracellular IFN-γ in CD4+ T cells. Supernatant from B. vulgatus 
prestimulated and E. coli mpk infected DC induced around 50% less IFN-γ production than 
only E. coli mpk infected DC supernatant (Figure 17B). Intracellular IFN-γ was also less at 
costimulated DC supernatant-primed T cells (7.9%) compared to intracellular IFN-γ (24.9%) 
of T cells primed by DC supernatant stimulated with only E. coli mpk. So this data suggests 
an inhibitory role of B. vulgatus in E. coli mpk mediated T cell polarization.   
 
3.2.6 E. coli mpk activated DC polarizes T cells 
DC recognizes pathogens with its pattern recognition receptors and become activated. During 
activation, DC upregulate its surface markers, e. g. costimulatory molecules, MHC  complex,  
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Figure 18: DC activated with colitogenic bacteria causes Th1 polarization in antigen 
specific T cells. Immature BMDC were stimulated with E. coli mpk or B. vulgatus or nothing for 1 
hour, treated with gentamicin and incubated for additional 23 hours, last 4 hours with 100μg/ml 
ovalbumin was added to the cultures. Naïve CD4+ T cells from spleen of OT-2 mice were stimulated 
with these stimulated DC for 4 days and IFN-γ and IL-4 were determined in the supernatant by 
ELISA. The error bars represent SD of duplicate. 
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chemokine receptors etc. and also secretes cytokines and chemokines. In the last sections we 
have demonstrated the role of secreted factors from pathogen-activated DC on T cell 
polarization. We have shown that E. coli mpk and B. vulgatus differentially induce IL-12, 
TNF-α secretion by DC and also upregulates activation and maturation markers differently. 
The different cytokine secretion by DC with E. coli mpk and B. vulgatus has an impact on T 
cell polarization (Figure 13). In addition to soluble factors direct cell-to cell interaction plays 
an important role in T cell stimulation. Therefore to address the role of differential activation 
and maturation marker on bacteria-stimulated DC was investigated. Immature BMDC were 
infected with E. coli mpk or B. vulgatus at MOI 1, cultures were treated with gentamicin after 
1 hour and cultured for additional 23 hours. DCs were pulsed with antigen, ovalbumin for last 
3 hours. Naïve CD4+ T cells from OT-II mice were stimulated with these stimulated DC for 4 
days and IFN-γ,  IL-4 levels were determined by ELISA. E. coli mpk infected DC polarized T 
cells to Th1 with high IFN-γ (6 ng/ml) but negligible IL-4 secretion. B. vulgatus infected DC 
induced less IFN-γ secretion (<2ng/ml) by T cells but more IL-4 secretion (10 pg/ml) 
compared to T cells primed by E. coli mpk infected DC (Figure 18). However DC primed 
with only antigen induced more IL-4 (25 pg/ml) secretion by antigen specific T cells than B. 
vulgatus stimulated antigen primed DC. It seems that in absence of active stimulus for Th1 
polarization, which mediates Th1 cytokine production (IFN-γ) and inhibits Th2 cytokine (IL-
4), naïve T cells produce IL-4. 
 
3.2.7 Heat killed E. coli mpk and B. vulgatus enhance antigen specific T helper cell 
response in vivo 
In IL-2-/- mice, E. coli mpk was found as colitogenic whereas B. vulgatus was non-colitogenic 
(121). It is known that IL-2-/- mice develop Th1 driven colitis (3). It was also shown in 
another study that E. coli and P. gingivalis LPS has different immune modulation capacity in 
vivo (84). Therefore, the T helper cell response against these two commensals, E. coli mpk 
and B. vulgatus in an antigen specific in vivo model was analyzed. For this purpose, 
splenocytes from DO11.10 mice (which contains 20% OVA-peptide 323-339 specific CD4+ T 
cells) were transferred intravenously to syngenic BALB/c mice. After 3 days these BALB/c 
mice were immunized intraperitoneally with 2 mg ovalbumin or 2 mg ovalbumin plus 200 µg 
heat killed E. coli mpk (HK E. coli mpk) or plus 200µg heat killed B. vulgatus (HK B. 
vulgatus) respectively. After 4 days immunized mice were sacrificed, splenocytes were 
prepared and expansion of OVA323-339 specific CD4+ T cells was analyzed. Furthermore 
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splenocytes were restimulated with different concentration of ovalbumin to analyze in vitro 
proliferation and cytokine production. It was found that CD4+ T cell population expanded in 
heat killed E. coli mpk as well as B. vulgatus treated reconstituted mice (Figure 19). A 
significant increase in OVA-peptide 323-339 specific T helper cell enhancement was only found 
in mice treated with ovalbumin and HK E. coli mpk compared to mice treated with ovalbumin 
alone. 
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Figure 19: E. coli mpk and B. vulgatus enhance T helper cell response in vivo. BALB/c 
mice reconstituted with DO11.10 T cells were induced intraperitoneally with soluble ovalbumin alone, 
heat killed E. coli mpk + ovalbumin or heat killed B. vulgatus + ovalbumin. After 4 days splenocytes 
were analyzed by flow cytometry for expansion of ovalbumin specific T helper cell by staining with 
anti-CD4 and Kj1-26(antibody against ova specific TCR). Figure shows percentage of expanded 
ovalbumin specific CD4+ T cells in spleen from a representative experiment. Data represents the mean 
of two mice in each group. 
 
3.2.8 Heat killed E. coli mpk and B. vulgatus induce antigen specific T helper cell 
polarization differently 
Splenocytes from mice reconstituted with OVA323-339 specific T cells and then immunized 
with soluble antigen with or without heat killed bacteria (as explained before) were 
restimulated in vitro for 72 hours with different concentration of ovalbumin. Culture 
supernatants were analyzed by ELISA to measure IFN-γ production by antigen specific T 
cells. Cells were pulsed with 3[H]-thymidine for last 16 hours to investigate T cell 
proliferation. .There was significant difference in IFN-γ production by cell culture from HK 
E. coli mpk and ovalbumin immunized mice compared to HK B. vulgatus and ovalbumin. HK 
E. coli mpk and ovalbumin immunization induced more IFN-γ secretion by T cells than HK 
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B. vulgatus and ovalbumin. But HK B. vulgatus and ovalbumin also induced some IFN-γ 
secretion in culture compared to only ovalbumin immunization (Figure 17). Both HK bacteria 
and soluble antigen stimulation induced significantly higher amounts of IL-10 secretion than 
only ovalbumin immunization (data not shown). T cells from mice treated only with 
ovalbumin proliferated nearly same like ovalbumin and heat killed bacteria immunized T cells 
when restimulated in vitro with ovalbumin (Figure 20). Therefore this data suggest that E. coli 
mpk, in heat-killed state is also able to enhance IFN-γ production by antigen specific T helper 
cell much better than heat killed B. vulgatus. 
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Figure 20: E. coli mpk enhances IFN-γ secretion by T helper cells compared to B. 
vulgatus. BALB/c mice reconstituted with DO11.10 T cells were induced intraperitoneally with 
soluble ovalbumin alone, heat killed E. coli mpk + ovalbumin or heat killed B. vulgatus + ovalbumin. 
Four days after immunization, splenocytes were restimulated with different concentration of 
ovalbumin and supernatants were analyzed for IFN-γ. Splenocytes were pulsed with 3[H]-thymidine 
for last 16 hours of culture and analyzed for cell proliferation. Data is from a representative 
experiment. 
 
 
3.3 Adipsin might have role in colitis prevention 
3.3.1 E. coli Nissle induces adipsin expression in colon of IL-2-/- mice 
It was found that IL-2-/- mice monocolonized with E. coli Nissle, B. vulgatus, B. vulgatus and 
E. coli mpk does not develop colitis. In contrast IL-2-/- mice monocolonized with E. coli mpk 
develop colitis at 22 weeks of age (121). IL-2-/- mice raised under specific pathogen free 
condition develops severe colitis. Another approach to analyze the mechanism(s) responsible 
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for developing colitis or prevention, the colonic total mRNA of differently colonized mice 
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Figure 21: Higher expression of adipsin was observed at colon of E. coli Nissle colonized 
IL-2-/- mice. Colonic total mRNA from IL-2-/- mice mono colonized with E. coli mpk, E. coli Nissle, 
B. vulgatus, cocolonized with E. coli mpk and B. vulgatus or wild type and IL-2-/- mice kept in specific 
pathogen free condition or germ free condition was isolated. A, RNA was analyzed by Affymetrix 
Gene array signals for adipsin expression are shown. B, adipsin expression was quantified by real 
time RT PCR normalized with GAPDH. Error bars represent SD of 5 mice. All mice were 8 weeks 
old. 
 
were analyzed by Affymetrix Gene Chip oligo microarray. One finding of this gene 
expression analysis was that several genes which are described to be mainly expressed by 
adipocytes such as adipsin, adiponectin seemed to be highly expressed in mice developing no 
colitis compared to mice developing colitis (Figure 21A). To confirm these findings 
semiquantitative RT-PCR was performed using mRNA from the colon of 5 single 8 weeks old 
mice per group. The highest expression for adipsin was found in IL-2-/- mice colonized with 
E. coli  Nissle.  E. coli mpk  mice, developing  colitis  expressed lower  amounts  of  adipsin  
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Figure 22: Immunohistochemical comparison of colonic sections from differently 
colonized IL-2-/- mice for adipsin. Colonic sections from 8 weeks old IL-2-/- mice mono colonized 
with E. coli mpk, E. coli Nissle, B. vulgatus or cocolonized with E. coli mpk and B. vulgatus were 
stained with anti- adipsin antibody and with hematoxyline/ eosin, examined at 40x magnification.  
 
compared to B. vulgatus or E. coli Nissle monocolonized mice (Figure 21B) (unpublished 
data kindly provided by a colleague from our group, Oliver Bechtold). To investigate which 
cell types in the mucosa is the source of adipsin, colon sections from differently colonized 
mice were assayed by immunohistology with antibody against adipsin (Figure 22). It is 
known that adipocytes are the main source of adipsin. Also epithelial cells, muscle cells 
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express adipsin (25,49,72,124). Immunohistochemical analysis of colon section from E. coli 
Nissle colonized IL-2-/- mice showed higher expression of adipsin in epithelial lining of 
intestinal mucosa. IL-2-/- mice double colonized with E. coli mpk and B. vulgatus also showed 
specific labeling of adipsin at intestinal epithelium. In contrast E. coli mpk monocolonized IL-
2-/- mice showed no specific labeling of adipsin in colonic sections.  
 
3.3.2 E. coli Nissle does not induce adipsin production by adipocytes in vitro 
To investigate if E. coli Nissle directly induces adipsin expression in cells, mouse intestinal 
epithelial cell line was (mICcl2) was infected with different bacteria and after 4 hours of 
infection mRNA was analyzed for adipsin expression by semiquantitative real time RT PCR. 
E. coli Nissle was unable to induce adipsin expression in epithelial cell line (data not shown). 
E. coli mpk, B. vulgatus was also unable to induce adipsin expression in epithelial cell line. 
It was found that in gastrointestinal tract adipose tissue surrounding the lymphoid cells 
interact with lymphoid cells. This interaction could be associated with protection against 
Helicobacter felis in a mouse infection model (74). Therefore we investigated whether E. coli 
Nissle is able to induce adipsin expression in adipose tissue and if there are differences in 
induction of adipsin by different bacteria. 3T3-L1, a preadipocyte cell line was used in this 
investigation. 3T3-L1 cells were grown to confluence. Subsequently 3T3-L1 cell line was 
infected with different bacteria at MOI 1, at day 0, 4 and 8 and cells were analyzed at day 10. 
E. coli Nissle as well as E. coli mpk and B. vulgatus were unable to induce adipsin expression 
in this cell line (Figure 23C) as analyzed by mRNA at day 10 by semiquantitative real time 
RT PCR. Similarly these bacteria were unable to differentiate this cell line to adipocyte 
(Figure 23A) as shown by ‘Oil red O’staining. E. coli Nissle and E. coli mpk and also B. 
vulgatus induced cell proliferation upon infection in this cell line compared to untreated cells 
shown by cell count (Figure 23B). Therefore this study excludes direct differentiation of 
adipocytes and adipsin expression in response to E. coli Nissle as well as other bacteria used 
in this study.  
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Figure 23: Infection of adipocyte cell line with different colitogenic and noncolitogenic 
bacteria is unable to induce adipsin expression. Preadipocyte cell line 3T3-L1 were infected 
with E. coli mpk, E. coli Nissle, B. vulgatus according to method and mRNA was analyzed at day 0, 5 
and 10 for adipsin expression. As positive control cells were stimulated with insulin, dexamethason 
and IBMX for first two days and then insulin was maintained in culture medium for rest of the 
incubation. A. Cell differentiation analyzed by ‘Oil red O’ staining, B, cell proliferation shown by cell 
count at day 10 and C, Adipsin expression was quantified by Taqman RT PCR and normalized with 
GAPDH. Error bars represent SD of duplicates. 
 
 
 
 
Results   64
3.3.3 Bacteria infected dendritic cell supernatant induces proliferation in 
preadipocyte cell line but does not induce adipsin expression 
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Figure 24: Infection of adipocyte cell line with supernatant of DC culture infected with 
different colitogenic and noncolitogenic bacteria is unable to induce adipsin expression. 
Preadipocyte cell line 3T3-L1 was infected with 10% supernatant from DC cultures which were 
infected with different colitogenic and probiotic bacteria. As positive control cells were stimulated 
with insulin, dexamethason and IBMX for first two days and then insulin was maintained in culture 
medium for rest of the incubation. A. Cell differentiation analyzed by ‘Oil red O’ staining, B, Cell 
proliferation shown by cell count at day 10 and C, Adipsin expression was quantified by real time RT 
PCR and normalized with GAPDH. Error bars represent SD of duplicates. 
 
It was assumed that E. coli Nissle does not directly induce adipsin in adipocyte of gut, rather 
it might be an indirect effect. May be E. coli Nissle induced gut associated lymphoid tissue in 
turn stimulate adipocytes to produce adipsin. To analyze this hypothesis, supernatant of DC 
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culture infected with E. coli Nissle, E. coli mpk or B. vulgatus was used to stimulate 
preadipocyte cell line, 3T3-L1. 3T3-L1 cells were grown to confluence and then were infected 
with 10% of differently infected DC supernatant at day 0, 4 and 8 and cells were analyzed at 
day 10. E. coli Nissle as well as E. coli mpk and B. vulgatus infected DC supernatant were 
unable to induce adipsin expression in this cell line as analyzed by Real time RT PCR. 
Bacteria induced DC factors were able to induce significant cell proliferation and only the DC 
factors induced by the both E. coli strains were able to differentiate this cell line to adipocyte 
in some extent compared to untreated cells (Figure 24). So this study also excludes a positive 
influence of DC mediated factors in adipsin expression by adipocyte in this experimental 
setup. 
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4 Discussion 
Multiple studies have led to the view that both environmental factors and genetic 
susceptibility contribute to pathological immunoregulatory events causing colitis (97). Among 
the environmental factors the microflora is more important. Uncontrolled immune responses 
to nonpathogenic luminal bacteria as a cause of colitis was also supported by clinical 
observations such as decreasing intestinal bacterial concentrations by various ways can lead to 
clinical improvement and decreased intestinal inflammation (94). Furthermore an IBD model, 
IL-2-/- mice develop colitis which is triggered by microflora (89). Microflora contains plenty 
of different bacterial strains, part of them can cause harm in altered physiological conditions. 
To assess this phenomenon some research has been done on gnotobiotic mice, selectively 
colonizing mice with one or two bacterial strains. Waidmann et al (121) colonized IL-2-/- 
mice with commensal strain, E. coli mpk or Bacteroides vulgatus. E. coli mpk strain was 
colitogenic for IL-2-/- mice but B. vulgatus was not colitogenic for it. Moreover B. vulgatus 
was able to suppress E. coli mpk induced colitis in co colonized IL-2-/- mice. Mono 
colonization of IL-2-/- mice with a well known probiotic E. coli Nissle 1917 was also free of 
colitis. Similar dependence on selective bacterial colonization was observed in germ free and 
gnotobiotic IL-10-/- mice. Germ free IL-10-/- mice developed IBD after they were colonized 
with Enterococcus feacalis. In contrast neither germ free IL-10-/- mice nor IL-10-/- mice 
colonized with a pure culture of Candida albicans, E. coli, Lactobacillus casei, L. ruteri, L. 
acidophilus, a Bifidobacterium species, Lactococcus lactis, or a Bacillus species developed 
IBD (4). 
In gut, commensals interact with gut associated lymphoid tissue, for example, epithelial cell, 
dendritic cell and then T cell. So this different colitogenic potential of different commensal 
strains might originate from different stimulation of gut associated lymphoid tissue and their 
cross talk.  
 
4.1 Different commensals differentiate DC differently 
DCs are distributed throughout the tissues, especially at the sites of interface with external 
environment. At mucosal interfaces, DC constantly survey and process commensal bacteria 
and pathogens and distinct DC subsets achieve this through different ways (45,46,48). In 
addition to acquiring antigens in the lamina propria, intestinal DCs located below specialized 
intestinal epithelial cells, M cells, also detect incoming pathogens. Recent evidence has 
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suggested that intestinal DC directly monitor the content of the intestinal lumen by either 
entering or extending dendrites into the epithelium (68,87). So DC is among the cells which 
encounters luminal bacteria. Therefore we investigated whether a DC in vitro model might 
help to explain how these bacteria may trigger or prevent colitis development in vivo. E. coli 
mpk induces higher IL-12, TNF-α, and IL-10 secretion by bone marrow derived dendritic 
cells than B. vulgatus. Also E. coli mpk induced higher expression of activation and 
maturation marker on BMDC than B. vulgatus. This data are in line with findings of other 
groups which show that different species of lactobacilli exert different DC activation patterns 
(22). BMDC were stimulated with six different lactobacilli strains in irradiated form. Among 
them Lactobacillus casei was a more potent inducer of cytokines (IL-12, IL-10, TNF-α and 
IL-6) and surface markers CD86 and MHC II by BMDC than Lactobacillus reuteri. The other 
four lactobacilli species were in between of the two strains in regards to BMDC activation and 
cytokine production. These data again demonstrates differential DC modulation by different 
bacteria which might be responsible for different colitis development in our in vivo colitis 
model.  
 
4.1.1 B. vulgatus differentiates DC into a semimature intermediate state 
It was found that stimulation of BMDC with B. vulgatus does not exert full activation and 
maturation of it. But the stimulated DC phenotype does not resemble to immature DC. Some 
recent data defined the semimature DCs as a DC phenotype which is phenotypically mature 
but functionally impaired. These DC express high levels of MHC II and co stimulatory 
molecules but show impaired cytokine expression (40,52,62). This phenotype is quite similar 
to the DC phenotype found after stimulation with B. vulgatus. After B. vulgatus treatment an 
impairement of IL-12 and TNF-α secretion by DC were observed. In addition the DC were 
unable to upregulate activation and maturation markers. Therefore, B. vulgatus stimulated DC 
were named as semimature/ intermediate DC.  
 
4.1.2 B. vulgatus inhibits E. coli mpk induced DC activation 
Because IL-2-/- mice cocolonized with E. coli mpk and B. vulgatus did not develop colitis 
(121), we investigated whether B. vulgatus can protect DC activation by E. coli mpk in an in 
vitro system. A recent study showed that L. reuteri was able to inhibit L. casei induced IL-12 
and TNF-α production by DC when added simultaneously (22). However, coculture of B. 
vulgatus with E. coli mpk did not prevent E. coli mpk induced TNF-α, IL-12 secretion. But 
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the pretreatment of DC with B. vulgatus converted DC in a state which made them inert 
against further E. coli mpk stimulation.  
The question is how B. vulgatus can make DC inert to further E. coli mpk stimulation. We 
observed that B. vulgatus induces only IL-6 production by DC, whereas E. coli mpk induces 
IL-6 in addition to TNF-α and IL-12 production by BMDC (Figure 3). We hypothesized that 
IL-6 in absence of IL-12 and TNF-α primes DC to an intermediate state which stays inert to 
further inflammatory stimulus. 
 
4.1.3 IL-6 plays important role in B. vulgatus mediated inhibition to DC 
IL-6 was originally identified as an antigen nonspecific B cell differentiation factor but later 
on role of IL-6 on other cell type was also discovered. IL-6 now known to have pleiotropic 
effects on cell growth, differentiation, survival, and migration during immune response, 
hemopoiesis, and inflammation. IL-6 receptor consists of an α-chain and gp-130, which is 
shared among the receptors for the other IL-6 family cytokines. Binding of IL-6 family 
cytokines to their receptors activates Janus kinases (JAK1, JAK2, and TYK2), leading to the 
recruitment of signal-transducing molecules such as SHP2 (Src homology region 2 domain 
containing phosphatase 2) and STAT3 (Signal transducer and activator of transcription 3) 
(42).  
Our data demonstrate an anti inflammatory role of IL-6. Pretreatment of DC with IL-6 as well 
as culture supernatant from DC infected with B. vulgatus (which contains IL-6 but no TNF-α 
or IL-12) converts immature DC to an intermediate DC, which is unable to become fully 
mature in response to E. coli mpk. Neutralization of IL-6 in culture supernatant of B. vulgatus 
primed DC was unable to induce intermediate DC and thus failed to inhibit DC activation by 
E. coli mpk. In line with our finding a recent study shows that IL-6 keeps DC in an immature/ 
resting state. Furthermore, pretreatment of DC with IL-6 can suppress LPS mediated 
activation of DC. Moreover enhanced expression of MHC II and CD86 on lymph node DC 
was observed in IL-6-/- mice compared to control mice. Similarly transgenic mice with 
increased signaling for IL-6 decreased the expression of these molecules on lymph node DC. 
In addition it was also found that STAT3 is required for the IL-6 mediated suppression of 
LPS-induced DC activation/ maturation. DC dependent T cell activation was enhanced in    
IL-6-/- mice but suppressed in gp130F759/F759 mice, in which gp130-mediated STAT3 
activation is enhanced (81). IL-6 was also shown to suppress CCR7 expression by DC (40) 
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which is necessary for migration of mature DC to lymphoid tissue. These recent findings also 
support this anti-inflammatory role of IL-6 in our system. 
 
4.1.4 It is hypothesized that less migratory capacity of B. vulgatus induced DC might 
play crucial role in colitis prevention 
IL-6 suppresses LPS induced NF-kB binding activity and NF-kB-dependent cytokine 
production and most importantly the chemokine receptor CCR7 expression (40). CCR7 is 
expressed on DC during maturation which is involved in homing of DC at lymph node where 
they encounter naïve T cells. In most nonlymphoide tissue DC are present as immature cells. 
These immature DC express low levels of costimulatory molecules and take up antigen very 
efficiently, but are poorly stimulatory for T cells. In response to maturation signals, which 
include microbial products and cytokines such as TNF-α, these cells change their pattern of 
expressed chemokine receptors and migrate to the draining lymphoid tissue (8). Immature DC 
express receptors for inflammatory chemokines and, upon induction of maturation, upregulate 
CCR7, a chemokine receptor that drives their migration to their lymphatics (27,91). CCR7 has 
two ligands, CCL21, which is expressed constitutively by endothelial cells of lymphatic 
vessels and of high endothelial venules (HEV) and by stromal cells present in the T cell zone, 
and CCL19, which is produced by stromal cells and mature DCs in the T cell zone 
(35,55,79,126). DC migration can be boosted in a paracrine fashion by TNF-α and by 
maturing DCs that are known to secrete TNF and other proinflammatory cytokines (69). 
CCR7 deficient mice has specific deficiency in T cell and DC homing into lymph nodes (31).  
Depending on recent data and our finding, we hypothesize that in vivo in IL-2-/- mice, E. coli 
mpk is able to cause maturation of intestinal DCs which migrate to lymph node and prime 
naïve T cells and is responsible for colitis development. In contrast B. vulgatus fails to induce 
maturation and also fails to upregulate CCR7 in intestinal DC. We speculate that these DC 
fail to migrate to lymph node, and do not start inflammation process. B. vulgatus primed DC 
secretes IL-6 which stimulates immature DC in a paracrine fashion to a semimature/ 
intermediate DC. For the situation when both bacteria are present in the gut lumen, we 
postulate that E. coli mpk activates DC and these DC migrate to lymph node to prime naïve T 
cells, but B. vulgatus converts immature DC to an intermediate phenotype with less 
costimulatory markers, MHC class II expression and secretes IL-6. This IL-6 converts more 
and more immature DC to an intermediate phenotype, which do not become activated when it 
face E. coli mpk later and thus impair colitis development. Higher expression of CCR7 on    
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E. coli mpk infected DCs compared to B. vulgatus infected DC supports this hypothesis 
(primary findings from a colleague of our group). More intensive study is necessary to 
evaluate and prove this hypothesis.  
However a recent study suggests that an abnormal pattern of DC maturation, such as mature 
cells fail to migrate but instead remain localized in the tissue might cause chronic 
inflammatory process (90). But it does not contradict with our hypothesis as the intermediate 
DC we propose to trap in lamina propria are functionally unable to induce T cell activation.  
 
4.2 E. coli mpk mediated T cells polarization towards Th1 cells 
correlates with the mechanism of colitis development in IL-2-/- mice 
It was shown that T cells but not B cells are involved in colitis development in IL-2-/- mice 
(63). Later involvement of CD4+ T cells rather than CD8+ T cells were also reported in bowel 
inflammation of IL-2-/- mice (105). Increased expression of IFN-γ mRNA was observed in 
colonic tissue of these mice (3) and cytokine pattern supports involvement of Th1 cells. 
Microflora triggers colitis in IL-2-/- mice and different strain of microflora has different 
influence on colitis development. (121). However, this T cell priming depends on the 
activation of antigen presenting cell present at mucosal area. Expression of MHC molecules, 
B-7 molecules (CD80, CD86), CD40 etc. on APC and secretion of cytokines, chemokines are 
a prerequisite for T cell priming.  
 
4.2.1 Cytokine microenvironment triggered by commensal has influence on colitis 
development 
It was found that E. coli mpk and B. vulgatus differentially induce cytokine expression by DC 
in vitro. T helper cell polarization depends on different cytokine environment created by DCs. 
The impact of different secreted factor from DC on T cells was analyzed. In vitro E. coli mpk 
infected DC supernatant polarizes T cell to Th1 with high IFN-γ production. In contrast B. 
vulgatus infected DC supernatant induces T cells to produce slight IL-4 but no IFN-γ, with a 
resemblance to a Th2/Th0 phenotype. E. coli mpk induces IL-12 production by DC which 
polarizes naïve T cells to Th1 direction. IL-12 is known as a key regulator of Th1 type 
immune responses by binding and signaling through the high affinity IL-12 receptor (7). 
Neutralization of IL-12 in E. coli mpk infected DC supernatant abolishes its Th1 polarizing 
capacity. 
Discussion   71
 
4.2.2 Costimulation by DC is also important for E. coli mpk induced T cell 
polarization 
T cell priming by activated DC requires specific binding of TCR with antigen loaded MHC 
molecule also called signal 1 and signal 2 via costimulatory molecule along with cytokine 
microenvironment (5). The influence of different cytokine environment created by different 
commensal infected DC is discussed in the last part. T cell stimulation in absence of 
costimulatory molecules results in T cell anergy while costimulation along with TCR  
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Figure 25: Schematic presentation of T cell priming by antigen loaded DC. 
 
stimulation leads to T cell priming. Differential costimulatory molecule expression by 
dendritic cell was observed with different commensals used in our system. So the impact of 
these commensal to induce differential expression of DC surface markers on T cell priming 
was analyzed. E. coli mpk induced higher expression of CD86, MHC-II and CD40 by DC 
which possesses Th1 polarization capacity, whereas B vulgatus induces medium expression of 
these molecules along with some IL-4 secretion by antigen specific transgenic T cells. Taken 
together this findings suggest in addition to secreted cytokines direct cell-to cell contact also 
plays a role in E. coli mpk mediated T cell polarization to Th1 cells. 
 
4.2.3 Structural difference in LPS of E. coli mpk and B. vulgatus might responsible 
for different immune reaction. 
The surface component, LPS of gram negative bacteria plays a role in their virulence. LPS 
contains three distinct structural domains, O-antigen, core and lipid A. The lipid A 
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(endotoxin) domain of LPS is a unique, glucosamine-based phospholipid that serves as the 
hydrophobic anchor of LPS and is the bioactive component of the molecule that is associated 
with gram-negative septic shock (116). The phosphate residue at the 4´position of sugar 
moiety is a critical site for the bioactivity and monophosphorylated form of lipid A must be 
responsible for the weak bioactivity of some LPS (88). Despite the common architecture, lipid 
A of different bacterial origin may vary in their fine structure. Variations in structure result 
from the type of hexosamine present, the degree of phosphorylation, the presence of 
phosphate substituents and most notably, the nature, chain length, number, and location of 
acyl groups (88). Different structure of LPS might be responsible for different immune 
response by different bacteria (84). Alteration in the hydrophobic region of E. coli lipid A, e. 
g. abstraction or addition of one acyl group also causes reduction of its bioactivity (88). 
It was shown that LPS from E. coli and P. gingivalis have different LPS structure which plays 
a role in differential cytokine production by DC and T cell polarization (84). P. gingivalis 
LPS contains multiple lipid A species, largest being pentacylated diphosphorylated species 
(57). Also tetra acylated monophosphorylated lipid A species present in P. gingivalis LPS. 
Interestingly it was found that the P. gingivalis LPS may activate host cells through either a 
TLR2- or a TLR4-dependent pathway (26). It was also reported that P. gingivalis LPS exerted 
antagonistic effects toward TLR4-dependent cell activation by E. coli LPS (23,130). The B. 
vulgatus LPS which contains lipid A carrying 4 fatty acids and one phosphate group, has 
similarity with P. gingivalis lipid A. B. vulgatus LPS showed significant less activity than E. 
coli LPS in inducing TNF-α production in human peripheral whole blood cells (39).We 
observed that heat killed B. vulgatus was weaker inducer for ovalbumin specific T helper cell 
in an adoptive transfer model than heat killed non pathogenic E. coli mpk and also has 
different T cell polarizing capacity (Figure 19). Correlating with above data from other groups 
we speculate that the difference in LPS structure between B. vulgatus and E. coli mpk might 
play a role in their different immune response but further experiments must be done with pure 
LPS from E. coli mpk and B. vulgatus to conclude the role of LPS in differetial DC activation 
and T cell polarization.  
 
4.2.4 Possible mechanism of colitis development correlating in vitro findings 
We hypothesize that in vivo B. vulgatus stimulates the IL-6 expression in colonic tissue but 
not the expression of proinflammatory cytokines like TNF-α and IL-12. This might lead to 
production of semimature/intermediate DC which are less responsive to E. coli mpk. This 
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semimature DC is functionally impaired, less migratory and functionally unable to activate T 
cell and thus does not mediate colitis. In contrast in vivo E. coli mpk activates DC and 
induces TNF-α, IL-12 and IL-6 secretion by DC. This phenotypically mature DC migrates to 
lymph node and there it activates T cells which cause colitis development. But when both the 
bacteria are present in vivo, B. vulgatus induces semimature DC which secretes IL-6, converts 
adjacent immature DCs to a semimature phenotype, and do not become activated by E. coli 
mpk later. Thus presence of semimature DC limits the E. coli mpk activated DC and prevents 
colitis in cocolonized mice. 
 
 
                  
CD4+ CD4+ CD4+
IL-6
IL-6
IL-12
TNF-α
IL-6
B. vulgatus E. coli B. vulgatus + E. coli
semimature mature semimature
MHC class II low
CD80/CD86 low
MHC class II low
CD80/CD86 low
MHC class II high
CD80/CD86 high
low IFN-γ
some IL-4
high IFN-γ
low IL-4
low IFN-γ
some IL-4
no colitis colitis no colitis
Immature DC
 
Figure 26: Schematic presentation of the mechanism involved in colitis development and 
prevention by the two commensals observed 
 
Further studies are required to demonstrate whether colonic DC are actually engaged by B. 
vulgatus and/or E. coli mpk in vivo and whether the gene expression is affected in colonic DC 
in a way as observed in vitro. 
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4.3 Adipocyte derived factors might play a role in colitis protection  
Probiotics offer physiologic, nontoxic treatment of pouchities, ulcerative colitis, and acute 
infectious dirrhoea. (93). E. coli Nissle 1917, a known probiotic is effective in maintaining 
remission in ulcerative colitis (56,86). In vitro studies showed that E. coli Nissle 1917 strain is 
strongly adherent to human intestinal epithelial cell line but no cytotoxicity is induced. 
Bordeau et al (11) hypothesized that its strong adhesion to intestinal epithelial cells could 
enable E. coli Nissle 1917 to form in vivo a biofilm of non-pathogenic bacteria that may 
prevent pathogenic micro-organisms from accessing the cell surface. E. coli Nissle also exerts 
a strong and specific inhibitory effect on adhesion of adherent-invasive E. coli strain to 
intestinal epithelial cells in both coinfection and preincubation experiment models (11). IL-2-/- 
mice, monocolonized with E. coli Nissle was colitis free with some increase in IFN-γ but no 
increase in TNF-α and CD14 at colon (121). Affymetrix Gene Chip oligo microarray from 
total mRNA of IL-2-/- mice with different colonization shows that E. coli Nissle 
monocolonized mice has higher expression of adipocyte derived factors, adipsin, adiponectin 
etc. at colonic tissue. Another colitis free group, IL-2-/- mice cocolonized with E. coli mpk and 
B. vulgatus also showed relatively higher expression of adipsin. But expression of these 
molecules were absent in IL-2-/- mice group that develop colitis.  
 
4.3.1 Cellular source of adipsin in colitis free IL-2-/-mice 
Adipsin is generally thought to be an adipocyte-specific gene (124) but also expressed in 
other tissues like monocyte/ macrophages, muscle, sciatic nerve, endometrium and intestine at 
low to moderate levels (25,49,72,124). Adipsin proteins are also detected at crypt region of 
intestinal mucosa (102). Immunohistological analysis of adipsin showed, specific staining in 
colonic section from E. coli Nissle monocolonized IL-2-/- mice as well as B. vulgatus, E. coli 
mpk cocolonized mice. The staining pattern suggests epithelial lining of colon might be the 
source of adipsin. Several epithelial cell lines, Mode K, mICcl2, CMT93, stimulated with E. 
coli Nissle were also unable to produce adipsin. Further investigation is necessary with 
different gut epithelial cell line as well as with primary epithelial cell with these commensals 
used in this study to conclude role of adipocyte factors in colitis prevention 
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4.3.2 Possible direct interaction between adipose tissue and commensals in colitis 
prevention were not observed 
Adipocyte is no longer considered as only a storage tissue. Recent data support its role in 
immune function. A molecular cross talk between adjacent lymphoid and adipose cell 
populations in gut was observed in protected stomach from helicobacter infection model (74). 
Helicobacter pylori are associated with acute chronic gastritis, peptic ulcer disease, and two 
gastric malignancies etc. H. felis is closely related to H. pylori, can colonize murine stomach 
and induce chronic active gastritis (58). In a recent investigation (74) mice were immunized 
with H. felis sonicates and cholera toxin and after two months mice were infected 
intragastrically with viable H. felis. Among the immunized group some mice were protected 
from H. felis infection. Gene expression profiling suggested a link between adipocyte derived 
factors with protection. Histological comparison also showed fat tissue surrounding the 
protected stomach contains clusters of lymphocytes that was absent in controls. 
Immunohistochemical analysis further specified binding of adipsin on lymphocytes embedded 
in fat tissue surrounding the stomach (74). 
This observation led us to analyze the influence of E. coli Nissle, or secreted factors from it as 
well as other colitogenic (E. coli mpk) and non-colitogenic (B. vulgatus) bacteria and their 
secreted factors on preadipocytes. No differential expression of adipsin, or preadipocyte 
differentiation was observed in vitro.  
 
4.3.3 Indirect interaction between E. coli Nissle and adipocytes were also ruled out in 
this in vitro system 
As dendritic cells are among the first cells that interact with luminal bacteria, we hypothesized 
that indirect interaction of adipocytes with commensal might be involved in colitis prevention 
in this IL-2-/- colitis model. Therefore we used different bacteria infected DC supernatant to 
stimulate preadipocyte cell line and analyzed adipsin expression. The indirect effect was also 
ruled out as bacteria infected dendritic cell supernatants did not influence adipsin expression 
by preadipocyte cell line, 3T3-L1. Our in vitro systems failed to explain the involvement of 
adipocyte derived factor in colitis protection in IL-2-/- mice. Further studies are necessary with 
different in vitro setup as well in vivo to understand the mechanism of colitis prevention by E. 
coli Nissle in IL-2-/- mouse model. 
 
.
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5 Summary:  
The cause of inflammatory bowel disease (IBD) is multifactorial and depends on genetic 
predisposition, environment (e.g. microflora) and the immune defense of the individual.      
IL-2-/- mice kept under germfree conditions develope no IBD. However a conventional 
microflora triggers colitis development. Therefore, IL-2-/- mice can be used as a model to 
study the role of the microflora for colitis development. The monocolonization of IL-2-/- mice 
with E. coli mpk triggers IBD while the co-colonization with B .vulgatus prevents IBD 
development. It was analyzed, how commensal bacteria might contribute to IBD development 
or prevention. At mucosal surfaces DC are among the first cells encountered by bacteria and 
play an important role in immune defense as well as maintenance of oral tolerance. The 
stimulation of DC with E. coli mpk in vitro leads to maturation of DC associated with 
increased IL-12, TNF-α, IL-10 und IL-6 secretion. E. coli mpk infected DC, pulsed with 
ovalbumin antigen trigger a strong T cell activation with high level of IFN-γ secretion as a 
marker for Th1 polarization in vitro, which is in line with the association of Th1 polarization 
and colitis development in vivo. B. vulgatus triggers only the secretion of IL-6 in DC and Th1 
polarization does not occur after antigen specific T cell stimulation. Moreover the 
prestimulation of E. coli mpk treated DC with supernatants derived from B. vulgatus treated 
DC or IL-6 alone prevents the E. coli mpk triggered maturation of DC in line with a reduced 
level of cytokine secretion and Th1 polarization. Therefore we postulate that B. vulgatus 
induced IL-6 secretion transits DC in a semimature/ inert state. Such DC might no longer be 
activated by E. coli mpk in vivo which may lead to a reduced migration of mature DC into 
lymph nodes, less subsequent T cell activation and therefore less colitis development. Further 
in vitro and in vivo studies are necessary to support this hypothesis. 
E. coli Nissle monocolonized mice which develop no colitis show a higher gene expression of 
adipocyte specific genes such as adipsin and adiponectin in the colon compared to E. coli mpk 
colonized IL-2-/- mice. Immunohistochemical analyses showed adipsin expression in epithelial 
cells. In an in vitro model system it was analysed whether adipocyte precursors can be 
converted in mature adipocytes by E. coli Nissle. This was not the case. Further studies have 
to be performed to investigate whether there is a functional association between E. coli Nissle 
induced adipsin expression and prevention of colitis development.
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6 Abbreviations 
 
3[H]-thymidine tritiated thymidine 
AA amino acid 
AICD Activation induced cell death 
APC Antigen presenting cell 
B Bacteroides 
BHI Brain heart infusion  
BMDC Bone marrow derived dendritic cell 
BSA bovine serum albumin 
CCL chemokine ligand 
CCR chemokine receptor 
CD Cluster of differentiation 
CD Crohn’s disease 
cDNA complimentary deoxy ribonucleic acid 
CFU colony forming unit 
Cox2 Cyclo oxygenase 2 
dATP deoxy adinosine triphosphate 
DC Dendritic cell 
dCTP deoxy cytosine triphosphate 
DEPC diethyl pyrocarbonate 
dGTP deoxy guanidine triphosphate 
dNTP deoxy necleoside triphosphate 
DSS dextran sodium sulfate 
DTT dithio threitol 
dTTP deoxy thymidine triphosphate 
E. coli Escherichia coli 
e.g. for example 
EDTA Ethylenediamine tetra acetic acid 
ELISA Enzyme linked immunosorbent assay 
et al. and others 
etc. etcetra 
FACS flourescence activated cell sorter 
FAE Follicle associated epithelium 
FCS fetal calf serum 
FITC fluoresceine isothiocyanate 
GALT  Gut associated lymphoid tissue 
GAPDH glyceraldehyde-3-phosphate dehydrogenase 
GF Germ free 
GI Gastrointestinal tract 
gp 130 glycoprotein 130 
H2O2 hydrogen peroxide 
HK heat killed 
IBD Inflammatory bowel disease 
IEC Intestinal epithelial cells 
IFN Interferon 
 
Ig G Immunoglobulin G 
IgA Immunoglobulin A 
IL Interleukin 
LB Luria bertani 
LPS lipopolysaccharide 
MACS magnetic-activated cell sorting 
MALT  Mucosa associated lymphoide tissue 
MHC Major histocompatibility complex 
MLN Mescenteric lymph node 
MOI multiplicity of infection 
mpk Max Pettenkofer 
NaCl Sodium chloride 
NCS neonatal calf serum 
NH4Cl ammonium chloride 
NK cell natural killer cell 
Ova ovalbumin 
PBS phosphate buffered saline 
PE phycoerythrin 
PerCP peridinin chlorophyll A protein 
PFA paraformaldehyde 
PGE2 Prostaglandin E2 
PMA phorbol myristate acetate 
PP Peyer’s Patches 
PRRs Pattern recognition receptors 
RAG Recombination-activating gene  
RNA Ribonucleic acid 
RNase Ribonuclease 
RT PCR reverse transcript polymerase chain reaction 
RT room temperature 
SCID Severe combined immunodeficient 
SD standard deviation 
SPF Specific pathogen free 
STAT Signal transducer and activator of transcription 
TCR T cell receptor 
Tg Transgenic 
TGF Transforming growth factor 
Th T helper cells 
TLR Toll like receptor 
TNBS Trinitrobenzene sulphonic acid 
TNF Tumor necrosis factor 
TNFR Tumor necrosis factor receptor 
Tr1 T regulatory cell 1 
UC Ulcerative colitis 
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